<?xml version="1.0" encoding="US-ASCII" standalone="yes" ?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version:  6.23.6 -->
<!-- Round: 6 -->
<!-- Creation date: 2016-11-09T21:07:34Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley &amp; Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:mpw="http://www.medicalpropertiestrust.com/20160930" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <xbrll:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="mpw-20160930.xsd" xlink:type="simple" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <us-gaap:UnsecuredDebtCurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20111031_0_1324529x1373899_1330926x1328370" decimals="-6" id="id_8591822_7B510C68-BDD8-4445-A34F-C05D94842724_2005_1" unitRef="iso4217_USD">60000000</us-gaap:UnsecuredDebtCurrent>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20111031_0_1324529x1373899_1330926x1409746" decimals="INF" id="id_8591822_7B510C68-BDD8-4445-A34F-C05D94842724_4005_4" unitRef="pure">0.05675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE631979--1610-Q0008_STD_0_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" decimals="-6" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_2001_1" unitRef="iso4217_USD">110000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20150811_0_1330096x1487397" decimals="-4" id="id_8591822_827F383D-9FB2-4C8C-A9AB-9FC3C4381AD0_1002_0" unitRef="shares">28750000</us-gaap:CommonStockSharesIssued>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20150819_0_1324529x1446616" decimals="INF" id="id_8591822_FDAB935F-126E-4D04-94D4-7BA24A6D82CC_1001_0" unitRef="iso4217_EUR">500000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160222_0_1324497x1326078_1324529x1497667" decimals="INF" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_3001_2" unitRef="pure">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160222_0_1324497x1326078_1324529x1497667" decimals="INF" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_3001_0" unitRef="iso4217_USD">500000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:NotesReceivableRelatedParties contextRef="eol_PE631979--1610-Q0008_STD_0_20160430_0_1326002x1439614" decimals="-6" id="id_8591822_553ADEB5-E9AF-4AB6-851F-D51A4E555BC3_1001_4" unitRef="iso4217_USD">50000000</us-gaap:NotesReceivableRelatedParties>
  <mpw:BusinessCombinationCommitmentToAdvanceAdditionalAmountForCapitalAdditions contextRef="eol_PE631979--1610-Q0008_STD_0_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103" decimals="-6" id="id_8591822_0EE6B9B5-2A62-4E85-B575-5B7C4BCB3A4F_2001_3" unitRef="iso4217_USD">30000000</mpw:BusinessCombinationCommitmentToAdvanceAdditionalAmountForCapitalAdditions>
  <us-gaap:UnsecuredDebtCurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20160731_0_1324529x1373899_1330926x1328370" decimals="-6" id="id_8591822_7B510C68-BDD8-4445-A34F-C05D94842724_2001_0" unitRef="iso4217_USD">65000000</us-gaap:UnsecuredDebtCurrent>
  <us-gaap:UnsecuredDebtCurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20161031_0_1324529x1373899_1335955x1330134" decimals="-6" id="id_8591822_6F6DD3B5-72F7-49B0-A8D2-02FB415F7E9D_1001_0" unitRef="iso4217_USD">60000000</us-gaap:UnsecuredDebtCurrent>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20161107_0" decimals="INF" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_2_5" unitRef="shares">320247632</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:ConvertibleDebt contextRef="eol_PE631979--1610-Q0008_STD_0_20120301_0" decimals="-5" id="id_8591822_9D351586-B445-4CE8-B6CE-50C02964D7E2_1001_1" unitRef="iso4217_USD">5000000</us-gaap:ConvertibleDebt>
  <mpw:LeaseAgreementInterestPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20150429_0_1325953x1439200_1326002x1455637" decimals="3" id="id_8591822_6B676F8A-6517-4ED7-8355-E4A59664FC4A_2001_4" unitRef="pure">0.093</mpw:LeaseAgreementInterestPercentage>
  <us-gaap:CommonStockValueOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20160301_0_1334258x1485840_1335482x1328677" decimals="-6" id="id_8591822_3993D3D3-516B-46AA-B646-C6ACB3E36F13_2001_0" unitRef="iso4217_USD">227000000</us-gaap:CommonStockValueOutstanding>
  <mpw:ContingentBusinessAcquisitionRelatedLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20150616_0_1325953x1439200_1334994x1393133" decimals="-5" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_4001_7" unitRef="iso4217_USD">12000000</mpw:ContingentBusinessAcquisitionRelatedLoans>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE631979--1610-Q0008_STD_0_20150727_0_1330063x1330534_1333690x1439614" decimals="INF" id="id_8591822_637715FC-7217-4E1C-A81F-892D9A1C92EF_2001_0" unitRef="iso4217_USD">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:SaleLeasebackTransactionHistoricalCost contextRef="eol_PE631979--1610-Q0008_STD_0_20160622_0_1325953x1430282_1326002x1455637" decimals="-5" id="id_8591822_316CA941-092E-4FF3-8B85-548858933EFE_1001_0" unitRef="iso4217_EUR">41600000</us-gaap:SaleLeasebackTransactionHistoricalCost>
  <mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20160622_0_1325953x1430282_1330098x1535290_1333690x1439614" decimals="-3" id="id_8591822_8DB70BE6-F140-4439-89E0-A78388D3B79C_2001_0" unitRef="iso4217_EUR">93262000</mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE631979--1610-Q0008_STD_0_20160720_0_1330098x1330786" decimals="-5" id="id_8591822_6FC8D2AE-1221-469D-9861-F292BACBB867_2002_1" unitRef="iso4217_EUR">215700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160722_0_1324529x1531691" decimals="INF" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_3001_3" unitRef="pure">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160722_0_1324529x1531691" decimals="INF" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_3001_0" unitRef="iso4217_USD">500000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1326002x1452282_1333690x1439614" decimals="INF" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_2001_4" unitRef="pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <mpw:NumberOfPortfolioInvestments contextRef="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1328644x1358103_1333690x1439614" decimals="INF" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_3001_0" unitRef="Investment">7</mpw:NumberOfPortfolioInvestments>
  <mpw:NumberOfPropertyInvestmentsMortgageLoan contextRef="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1328644x1358103_1333690x1439614" decimals="INF" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_3001_1" unitRef="Investment">2</mpw:NumberOfPropertyInvestmentsMortgageLoan>
  <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1333690x1439614" decimals="2" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_4001_6" unitRef="pure">0.51</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1333690x1439614" decimals="2" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_4001_5" unitRef="pure">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <mpw:CombinedPurchasePriceAndInvestmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1333690x1439614" decimals="-6" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_4001_2" unitRef="iso4217_USD">900000000</mpw:CombinedPurchasePriceAndInvestmentAmount>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20150909_0_1325953x1439200_1328480x1409831" decimals="2" id="id_8591822_8A88D022-FCBE-4292-81FA-9CC4D2AA8F5B_1001_0" unitRef="pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0" decimals="INF" id="id_8591822_FE5F7E7A-74F2-4AC2-8B17-975477CE85A2_1_3" unitRef="iso4217_USD">1950000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1002_44" unitRef="iso4217_USD">52388000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1002_39" unitRef="iso4217_USD">332235000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_2002_9" unitRef="iso4217_USD">1634347000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_2002_7" unitRef="iso4217_USD">2020198000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_2002_8" unitRef="iso4217_USD">385851000</mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1324497x1326078" decimals="INF" id="id_8591822_FE5F7E7A-74F2-4AC2-8B17-975477CE85A2_2001_0" unitRef="iso4217_USD">1300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <mpw:LineOfCreditMaximumBorrowingCapacityIncludingAccordionOption contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1324497x1326078" decimals="INF" id="id_8591822_FE5F7E7A-74F2-4AC2-8B17-975477CE85A2_2001_2" unitRef="iso4217_USD">400000000</mpw:LineOfCreditMaximumBorrowingCapacityIncludingAccordionOption>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1324529x1373522" decimals="INF" id="id_8591822_FE5F7E7A-74F2-4AC2-8B17-975477CE85A2_3001_1" unitRef="iso4217_USD">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:SaleLeasebackTransactionHistoricalCost contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1325953x1439200_1326002x1455637" decimals="-6" id="id_8591822_69DE2CF8-45DC-414B-B356-81CCD004A5AA_2001_1" unitRef="iso4217_EUR">627000000</us-gaap:SaleLeasebackTransactionHistoricalCost>
  <mpw:ContingentBusinessAcquisitionRelatedLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1325953x1439200_1326002x1455637" decimals="-6" id="id_8591822_C9C274BC-CE8F-464B-B316-D5BE4F7C4203_1003_2" unitRef="iso4217_EUR">240000000</mpw:ContingentBusinessAcquisitionRelatedLoans>
  <mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1326002x1455637" decimals="-3" id="id_8591822_65261730-7235-4993-A3B2-558CBBBF6F5E_1002_0" unitRef="iso4217_USD">385851000</mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1327299x1461762" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_3002_6" unitRef="iso4217_USD">514484000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_2002_44" unitRef="iso4217_USD">52388000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_2002_39" unitRef="iso4217_USD">332235000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1331645x1335058" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_4002_4" unitRef="iso4217_USD">365000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1324247" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_5002_1" unitRef="iso4217_USD">711805000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1325370" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_6002_0" unitRef="iso4217_USD">113309000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1394035" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_7002_5" unitRef="iso4217_USD">170700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1487449" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_8002_2" unitRef="iso4217_USD">144900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE631979--1610-Q0008_STD_0_20160909_0_1330098x1330786" decimals="-5" id="id_8591822_D5F8F3A9-193B-4491-8B17-5ACC27399C3D_3002_1" unitRef="iso4217_EUR">46300000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE631979--1610-Q0008_STD_0_20160928_0_1330098x1534851" decimals="-6" id="id_8591822_ECB6E727-76BC-4170-8359-8AF036C61305_2001_1" unitRef="iso4217_USD">105000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_25" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_28" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_30" unitRef="shares">309792000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_27" unitRef="iso4217_USD_per_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_29" unitRef="shares">309792000</us-gaap:CommonStockSharesIssued>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_24" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_23" unitRef="iso4217_USD_per_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_32" unitRef="iso4217_USD">-402632000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PreferredStockValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_22" unitRef="iso4217_USD" xsi:nil="true"/>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_4" unitRef="iso4217_USD">224700000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
  <us-gaap:LongTermDebtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_73054E8E-F8A7-4A9B-A06D-46AF7C520755_1001_2" unitRef="iso4217_USD">2875619000</us-gaap:LongTermDebtFairValue>
  <us-gaap:Liabilities contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_20" unitRef="iso4217_USD">2929371000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_38" unitRef="iso4217_USD">6095337000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DeferredRevenueLeasesNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_1_2" unitRef="iso4217_USD">1643300000</us-gaap:DeferredRevenueLeasesNet>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_33" unitRef="iso4217_USD">-60036000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_35" unitRef="iso4217_USD">3161053000</us-gaap:StockholdersEquity>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_18" unitRef="iso4217_USD">24528000</us-gaap:DeferredRevenue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_1001_14" unitRef="iso4217_USD">2728549000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:CommonStockValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_26" unitRef="iso4217_USD">310000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_31" unitRef="iso4217_USD">3623673000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_1" unitRef="iso4217_USD">320000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_0" unitRef="iso4217_USD">60078000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_37" unitRef="iso4217_USD">3165966000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:MinorityInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_36" unitRef="iso4217_USD">4913000</us-gaap:MinorityInterest>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_3" unitRef="iso4217_USD">250000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_2" unitRef="iso4217_USD">12781000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:LongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_6" unitRef="iso4217_USD">2759629000</us-gaap:LongTermDebt>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1001_44" unitRef="iso4217_USD">58333000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_17" unitRef="iso4217_USD">149190000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_1_3" unitRef="iso4217_USD">533491000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_12" unitRef="iso4217_USD">242107000</us-gaap:OtherAssets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_8" unitRef="iso4217_USD">1094917000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1004_2" unitRef="iso4217_USD">222435000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:LoansHeldForSaleFairValueDisclosure contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_73054E8E-F8A7-4A9B-A06D-46AF7C520755_1001_1" unitRef="iso4217_USD">529053000</us-gaap:LoansHeldForSaleFairValueDisclosure>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_4" unitRef="iso4217_USD">550118000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_2001_9" unitRef="iso4217_USD">119838000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_1_0" unitRef="iso4217_USD">1884144000</us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1004_1" unitRef="iso4217_USD">222435000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:ReceivablesFairValueDisclosure contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_73054E8E-F8A7-4A9B-A06D-46AF7C520755_1001_0" unitRef="iso4217_USD">54522000</us-gaap:ReceivablesFairValueDisclosure>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_13" unitRef="iso4217_USD">6095337000</us-gaap:Assets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_2001_7" unitRef="iso4217_USD">213100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_2004_1" unitRef="iso4217_USD">715902000</us-gaap:LoansReceivableNet>
  <us-gaap:TreasuryStockValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_34" unitRef="iso4217_USD">262000</us-gaap:TreasuryStockValue>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_10" unitRef="iso4217_USD">103413000</mpw:StraightLineRentReceivable>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_19" unitRef="iso4217_USD">27104000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_2001_8" unitRef="iso4217_USD">93262000</mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans>
  <mpw:Loans contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_614CF472-97FB-4297-BD34-3D81F90DECCE_1001_1" unitRef="iso4217_USD">496767000</mpw:Loans>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_7" unitRef="iso4217_USD">4434562000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_F91F0BA3-2C49-43CD-A102-3E3D0155640E_1001_5" unitRef="iso4217_USD">2211750000</mpw:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_6" unitRef="iso4217_USD">301262000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:RemainingConvertibleDebtAfterConversionOfPartOfDebt contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-5" id="id_8591822_9D351586-B445-4CE8-B6CE-50C02964D7E2_1002_3" unitRef="iso4217_USD">3300000</mpw:RemainingConvertibleDebtAfterConversionOfPartOfDebt>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_614CF472-97FB-4297-BD34-3D81F90DECCE_1001_0" unitRef="iso4217_USD">54554000</mpw:InterestAndRentReceivable>
  <mpw:OtherLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_11" unitRef="iso4217_USD">165784000</mpw:OtherLoans>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_5" unitRef="iso4217_USD">4735824000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:EstimatedResidualValues contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_1_1" unitRef="iso4217_USD">292647000</mpw:EstimatedResidualValues>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2006_1" unitRef="iso4217_USD">201184000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_1_2" unitRef="iso4217_USD">3652215000</mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1359699" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_2003_1" unitRef="iso4217_USD">43623000</us-gaap:LoansReceivableNet>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1391302" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_2002_1" unitRef="iso4217_USD">122161000</us-gaap:LoansReceivableNet>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1531684_1327299x1461762_1331211x1328015" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1002_2" unitRef="iso4217_USD">116585000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1531684_1327299x1461762_1331211x1328015" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1002_1" unitRef="iso4217_USD">116585000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324199x1385482" decimals="INF" id="id_8591822_7AFE241C-B6F7-419E-BAED-F5777A251AA7_1001_0" unitRef="shares">8196770</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324199x1385482" decimals="INF" id="id_8591822_7AFE241C-B6F7-419E-BAED-F5777A251AA7_1001_1" unitRef="shares">4763066</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1373522" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_3001_11" unitRef="iso4217_USD">263179000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1373899_1330926x1331595" decimals="-5" id="id_8591822_7B510C68-BDD8-4445-A34F-C05D94842724_3002_2" unitRef="iso4217_USD">400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1438241" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_5001_12" unitRef="iso4217_USD">2761531000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535158" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_6001_9" unitRef="pure">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535158" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_6001_9" unitRef="iso4217_USD">500000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535159" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_7001_10" unitRef="pure">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535159" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_7001_10" unitRef="iso4217_USD">500000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535294" decimals="5" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_8001_2" unitRef="pure">0.05675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535294" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_8001_1" unitRef="iso4217_USD">60000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535295" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_9001_4" unitRef="pure">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentUnamortizedPremium contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535295" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_9001_4" unitRef="iso4217_USD">1902000</us-gaap:DebtInstrumentUnamortizedPremium>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535295" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_9001_5" unitRef="iso4217_USD">351902000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:LongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535295" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_9001_3" unitRef="iso4217_USD">350000000</us-gaap:LongTermDebt>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535296" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_10001_6" unitRef="pure">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535296" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_10001_6" unitRef="iso4217_USD">224700000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535297" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_11001_7" unitRef="pure">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535297" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_11001_7" unitRef="iso4217_USD">300000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535298" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_12001_8" unitRef="pure">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535298" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_12001_8" unitRef="iso4217_USD">561750000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1331409_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_1001_25" unitRef="shares">3095000</us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:GeneralPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1331409_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_1001_24" unitRef="shares">3095000</us-gaap:GeneralPartnersCapitalAccountUnitsIssued>
  <us-gaap:GeneralPartnersCapitalAccount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1331409_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_1001_23" unitRef="iso4217_USD">32235000</us-gaap:GeneralPartnersCapitalAccount>
  <us-gaap:LimitedPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1432756_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_2001_31" unitRef="shares">292000</us-gaap:LimitedPartnersCapitalAccountUnitsIssued>
  <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1432756_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_2001_32" unitRef="shares">292000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
  <mpw:OutstandingAmountReceivableFromTenantPastDueRentAndInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325942x1455126" decimals="-5" id="id_8591822_AE1D5722-6F4E-46B2-89AA-C305907396F1_1004_0" unitRef="iso4217_USD">2500000</mpw:OutstandingAmountReceivableFromTenantPastDueRentAndInterest>
  <mpw:NumberOfFacilitiesConstructed contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325953x1388500_1328644x1353251" decimals="INF" id="id_8591822_AFCBBA9A-9AC2-48C3-B970-C1993FE5058A_1001_0" unitRef="Facility">13</mpw:NumberOfFacilitiesConstructed>
  <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327271x1334937" decimals="INF" id="id_8591822_793D7D0B-D87D-4C59-86F1-44D112205FBD_1_1" unitRef="iso4217_USD">306928000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
  <us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327299x1325719" decimals="-3" id="id_8591822_76E96A22-4997-4C9C-ABA0-7B09CED92061_2_1" unitRef="iso4217_USD">207000</us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327299x1325719_1331211x1328015_1334317x1324867" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1003_2" unitRef="iso4217_USD">3300000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327299x1325719_1331211x1328015_1334317x1324867" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1003_1" unitRef="iso4217_USD">3300000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328406x1370426_1331211x1328015_1331645x1335058" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1001_2" unitRef="iso4217_USD">102550000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328406x1370426_1331211x1328015_1331645x1335058" decimals="-3" id="id_8591822_24DEE45B-320B-4CD5-9059-475F2DDD5D5E_1001_1" unitRef="iso4217_USD">102550000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="INF" id="id_8591822_A0780882-F0A9-41EB-A43B-6BEDD056DE4A_4001_0" unitRef="pure">0.9987</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <us-gaap:Liabilities contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_21" unitRef="iso4217_USD">2928981000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_37" unitRef="iso4217_USD">6095337000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_33" unitRef="iso4217_USD">-60036000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_34" unitRef="iso4217_USD">3161443000</us-gaap:StockholdersEquity>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_18" unitRef="iso4217_USD">24528000</us-gaap:DeferredRevenue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_16" unitRef="iso4217_USD">2728549000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_36" unitRef="iso4217_USD">3166356000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:MinorityInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_35" unitRef="iso4217_USD">4913000</us-gaap:MinorityInterest>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_2001_44" unitRef="iso4217_USD">58333000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_17" unitRef="iso4217_USD">90430000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_3" unitRef="iso4217_USD">533491000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_12" unitRef="iso4217_USD">242107000</us-gaap:OtherAssets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_8" unitRef="iso4217_USD">1094917000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_4" unitRef="iso4217_USD">550118000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_13" unitRef="iso4217_USD">6095337000</us-gaap:Assets>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_10" unitRef="iso4217_USD">103413000</mpw:StraightLineRentReceivable>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_19" unitRef="iso4217_USD">27104000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_7" unitRef="iso4217_USD">4434562000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_6" unitRef="iso4217_USD">301262000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_9" unitRef="iso4217_USD">54554000</mpw:InterestAndRentReceivable>
  <mpw:OtherLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_11" unitRef="iso4217_USD">165784000</mpw:OtherLoans>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_5" unitRef="iso4217_USD">4735824000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:PayableDueToParentCompany contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_20" unitRef="iso4217_USD">58370000</mpw:PayableDueToParentCompany>
  <mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3001_2" unitRef="iso4217_USD">3652215000</mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther>
  <us-gaap:CommonUnitIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026_1330097x1333806" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_4001_28" unitRef="shares">306697000</us-gaap:CommonUnitIssued>
  <us-gaap:CommonUnitOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026_1330097x1333806" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_4001_29" unitRef="shares">306697000</us-gaap:CommonUnitOutstanding>
  <us-gaap:LimitedPartnersCapitalAccount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026_1330097x1333806" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_4001_27" unitRef="iso4217_USD">3189244000</us-gaap:LimitedPartnersCapitalAccount>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330096x1487397" decimals="-5" id="id_8591822_55D05A39-DA4C-4FD7-B4EB-9CDF85556F7A_2001_0" unitRef="shares">57500000</us-gaap:CommonStockSharesIssued>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1325518_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3001_1" unitRef="iso4217_USD">1250000000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1330589_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3003_1" unitRef="iso4217_USD">542892000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1330786_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3007_1" unitRef="iso4217_USD">1376626000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1336058_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3002_1" unitRef="iso4217_USD">944028000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1336103_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3006_1" unitRef="iso4217_USD">5657908000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1377380_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3004_1" unitRef="iso4217_USD">2669401000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1378289_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3010_1" unitRef="iso4217_USD">1559869000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1402629_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3008_1" unitRef="iso4217_USD">156226000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1529443_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3005_1" unitRef="iso4217_USD">251587000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1529444_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3009_1" unitRef="iso4217_USD">27017000</us-gaap:Assets>
  <us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330328x1447101" decimals="-3" id="id_8591822_76E96A22-4997-4C9C-ABA0-7B09CED92061_1_1" unitRef="iso4217_USD">226117000</us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets>
  <us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330926x1328370" decimals="-5" id="id_8591822_37B8B1E6-8B7F-463F-B684-6D3FEF1E062D_1001_0" unitRef="iso4217_USD">400000</us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1331645x1335058" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_2001_1" unitRef="iso4217_USD">550118000</us-gaap:LoansReceivableNet>
  <mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333690x1439614" decimals="-3" id="id_8591822_65261730-7235-4993-A3B2-558CBBBF6F5E_1001_0" unitRef="iso4217_USD">93262000</mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans>
  <mpw:NumberOfInvestments contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1324536" decimals="INF" id="id_8591822_3E97CE09-627A-4AD5-94E1-20FFE5B12A56_1001_0" unitRef="Investment">0</mpw:NumberOfInvestments>
  <mpw:MaximumPercentageOfEntitysGrossAssetsInvestedOnSingleProperty contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1324536" decimals="INF" id="id_8591822_3E97CE09-627A-4AD5-94E1-20FFE5B12A56_1001_1" unitRef="pure">0.033</mpw:MaximumPercentageOfEntitysGrossAssetsInvestedOnSingleProperty>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_3011_1" unitRef="iso4217_USD">7217777000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1393133" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_3004_1" unitRef="iso4217_USD">622416000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1455637" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_3003_1" unitRef="iso4217_USD">1054568000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1491880" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_3002_1" unitRef="iso4217_USD">1142760000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1531683" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_3005_1" unitRef="iso4217_USD">564509000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1534840" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_3001_1" unitRef="iso4217_USD">1250000000</us-gaap:Assets>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334258x1485840" decimals="-6" id="id_8591822_3993D3D3-516B-46AA-B646-C6ACB3E36F13_1002_2" unitRef="shares">15000000</us-gaap:CommonStockSharesIssued>
  <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334317x1324867" decimals="INF" id="id_8591822_793D7D0B-D87D-4C59-86F1-44D112205FBD_2_1" unitRef="iso4217_USD">32325000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
  <us-gaap:MortgageLoansOnRealEstate contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1352243" decimals="-5" id="id_8591822_99DA6A52-DFD1-48B0-B8DB-DDBD668D56BB_1001_0" unitRef="iso4217_USD">93200000</us-gaap:MortgageLoansOnRealEstate>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1393133" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2004_1" unitRef="iso4217_USD">28067000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1529440" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2001_1" unitRef="iso4217_USD">32684000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1529441" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2002_1" unitRef="iso4217_USD">11578000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1529442" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2003_1" unitRef="iso4217_USD">69801000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1531679" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2005_1" unitRef="iso4217_USD">59054000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1324247" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_5001_1" unitRef="iso4217_USD">125472000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1325370" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_6001_0" unitRef="iso4217_USD">13874000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1394035" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_7001_5" unitRef="iso4217_USD">63000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1487449" decimals="-3" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_8001_2" unitRef="iso4217_USD">10754000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="eol_PE631979--1610-Q0008_STD_0_20161001_0_1330098x1330786_1335955x1330134" decimals="-5" id="id_8591822_D5F8F3A9-193B-4491-8B17-5ACC27399C3D_4004_3" unitRef="iso4217_EUR">22900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
  <mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="-6" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_2001_4" unitRef="iso4217_USD">600000000</mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans>
  <mpw:NumberOfFacilitiesForWhichMortgageFinancingWasProvided contextRef="eol_PE631979--1610-Q0008_STD_0_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="INF" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_2001_9" unitRef="Facility">4</mpw:NumberOfFacilitiesForWhichMortgageFinancingWasProvided>
  <mpw:CombinedPurchasePriceAndInvestmentAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="-7" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_2001_1" unitRef="iso4217_USD">1250000000</mpw:CombinedPurchasePriceAndInvestmentAmount>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE631979--1610-Q0008_STD_0_20161007_0_1326002x1433225_1330097x1333806_1330125x1329075_1335955x1330134" decimals="INF" id="id_8591822_7AFE1339-3B89-4639-8265-28FB47C5A04B_2001_1" unitRef="iso4217_USD_per_shares">14.50</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20141231_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2001_38" unitRef="iso4217_USD">144541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="eol_PE631979--1610-Q0008_STD_0_20141231_0_1325953x1439200_1326002x1455637" decimals="3" id="id_8591822_C9C274BC-CE8F-464B-B316-D5BE4F7C4203_1001_1" unitRef="pure">0.051</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <mpw:ContingentBusinessAcquisitionRelatedLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20141231_0_1325953x1439200_1326002x1455637" decimals="-6" id="id_8591822_C9C274BC-CE8F-464B-B316-D5BE4F7C4203_1002_3" unitRef="iso4217_EUR">425000000</mpw:ContingentBusinessAcquisitionRelatedLoans>
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="eol_PE631979--1610-Q0008_STD_0_20141231_0_1325953x1439200_1326002x1455637_1333690x1348598" decimals="3" id="id_8591822_C9C274BC-CE8F-464B-B316-D5BE4F7C4203_2001_0" unitRef="pure">0.949</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20141231_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_3001_38" unitRef="iso4217_USD">144541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20150114_0_1330096x1487397" decimals="-5" id="id_8591822_86320518-3EA8-4DA3-BB20-E0F7881CEEC0_1002_0" unitRef="shares">34500000</us-gaap:CommonStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_25" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_28" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_30" unitRef="shares">236744000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_27" unitRef="iso4217_USD_per_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_29" unitRef="shares">236744000</us-gaap:CommonStockSharesIssued>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_24" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="INF" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_23" unitRef="iso4217_USD_per_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_32" unitRef="iso4217_USD">-418650000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PreferredStockValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_22" unitRef="iso4217_USD" xsi:nil="true"/>
  <us-gaap:LongTermDebtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_73054E8E-F8A7-4A9B-A06D-46AF7C520755_1002_2" unitRef="iso4217_USD">3372773000</us-gaap:LongTermDebtFairValue>
  <us-gaap:Liabilities contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_20" unitRef="iso4217_USD">3502086000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_38" unitRef="iso4217_USD">5609351000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DeferredRevenueLeasesNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_2_2" unitRef="iso4217_USD">2354013000</us-gaap:DeferredRevenueLeasesNet>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_33" unitRef="iso4217_USD">-72884000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_35" unitRef="iso4217_USD">2102268000</us-gaap:StockholdersEquity>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_18" unitRef="iso4217_USD">29358000</us-gaap:DeferredRevenue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_1002_14" unitRef="iso4217_USD">3322541000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:CommonStockValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_26" unitRef="iso4217_USD">237000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_31" unitRef="iso4217_USD">2593827000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_37" unitRef="iso4217_USD">2107265000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:MinorityInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_36" unitRef="iso4217_USD">4997000</us-gaap:MinorityInterest>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_17" unitRef="iso4217_USD">137356000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_2_3" unitRef="iso4217_USD">626996000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_12" unitRef="iso4217_USD">195540000</us-gaap:OtherAssets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_8" unitRef="iso4217_USD">195541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:LoansHeldForSaleFairValueDisclosure contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_73054E8E-F8A7-4A9B-A06D-46AF7C520755_1002_1" unitRef="iso4217_USD">543859000</us-gaap:LoansHeldForSaleFairValueDisclosure>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_4" unitRef="iso4217_USD">757581000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_2_0" unitRef="iso4217_USD">2587912000</us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable>
  <us-gaap:ReceivablesFairValueDisclosure contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_73054E8E-F8A7-4A9B-A06D-46AF7C520755_1002_0" unitRef="iso4217_USD">46858000</us-gaap:ReceivablesFairValueDisclosure>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_13" unitRef="iso4217_USD">5609351000</us-gaap:Assets>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_1004_2" unitRef="iso4217_USD">1422403000</us-gaap:LoansReceivableNet>
  <us-gaap:TreasuryStockValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_34" unitRef="iso4217_USD">262000</us-gaap:TreasuryStockValue>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_10" unitRef="iso4217_USD">82155000</mpw:StraightLineRentReceivable>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_19" unitRef="iso4217_USD">12831000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:Loans contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_614CF472-97FB-4297-BD34-3D81F90DECCE_1002_1" unitRef="iso4217_USD">508851000</mpw:Loans>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_7" unitRef="iso4217_USD">4424354000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_6" unitRef="iso4217_USD">257928000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_614CF472-97FB-4297-BD34-3D81F90DECCE_1002_0" unitRef="iso4217_USD">46939000</mpw:InterestAndRentReceivable>
  <mpw:OtherLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_11" unitRef="iso4217_USD">664822000</mpw:OtherLoans>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_5" unitRef="iso4217_USD">4682282000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:EstimatedResidualValues contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_0E638B61-E4EE-4669-A055-392561D1EF68_2_1" unitRef="iso4217_USD">393097000</mpw:EstimatedResidualValues>
  <mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0" decimals="-3" id="id_8591822_E141B412-8BEA-4630-87DE-60651BC5E8BC_2_2" unitRef="iso4217_USD">3297705000</mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324069x1359699" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_1003_2" unitRef="iso4217_USD">54353000</us-gaap:LoansReceivableNet>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324069x1391302" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_1002_2" unitRef="iso4217_USD">610469000</us-gaap:LoansReceivableNet>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324497x1326078" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_2002_0" unitRef="iso4217_USD">1100000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1373522" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_3002_11" unitRef="iso4217_USD">263400000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1373899_1330926x1331595" decimals="-5" id="id_8591822_7B510C68-BDD8-4445-A34F-C05D94842724_3003_2" unitRef="iso4217_USD">2900000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1435109" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_5002_3" unitRef="pure">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1435109" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_4002_2" unitRef="iso4217_USD">450000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1438241" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_5002_12" unitRef="iso4217_USD">3350908000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535294" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_8002_1" unitRef="iso4217_USD">125000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535295" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_9002_4" unitRef="pure">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentUnamortizedPremium contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535295" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_9002_4" unitRef="iso4217_USD">2168000</us-gaap:DebtInstrumentUnamortizedPremium>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535295" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_9002_5" unitRef="iso4217_USD">352168000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:LongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535295" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_9002_3" unitRef="iso4217_USD">350000000</us-gaap:LongTermDebt>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535296" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_10002_6" unitRef="pure">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535296" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_10002_6" unitRef="iso4217_USD">217240000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535297" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_11002_7" unitRef="pure">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535297" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_11002_7" unitRef="iso4217_USD">300000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535298" decimals="INF" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_12002_8" unitRef="pure">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535298" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_12002_8" unitRef="iso4217_USD">543100000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1331409_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_1002_25" unitRef="shares">2363000</us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:GeneralPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1331409_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_1002_24" unitRef="shares">2363000</us-gaap:GeneralPartnersCapitalAccountUnitsIssued>
  <us-gaap:GeneralPartnersCapitalAccount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1331409_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_1002_23" unitRef="iso4217_USD">21773000</us-gaap:GeneralPartnersCapitalAccount>
  <us-gaap:LimitedPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1432756_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_2002_31" unitRef="shares">292000</us-gaap:LimitedPartnersCapitalAccountUnitsIssued>
  <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1432756_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_2002_32" unitRef="shares">292000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:Liabilities contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_21" unitRef="iso4217_USD">3501696000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_37" unitRef="iso4217_USD">5609351000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_33" unitRef="iso4217_USD">-72884000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_34" unitRef="iso4217_USD">2102658000</us-gaap:StockholdersEquity>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_18" unitRef="iso4217_USD">29358000</us-gaap:DeferredRevenue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_16" unitRef="iso4217_USD">3322541000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_36" unitRef="iso4217_USD">2107655000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:MinorityInterest contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_35" unitRef="iso4217_USD">4997000</us-gaap:MinorityInterest>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_17" unitRef="iso4217_USD">84628000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_3" unitRef="iso4217_USD">626996000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_12" unitRef="iso4217_USD">195540000</us-gaap:OtherAssets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_8" unitRef="iso4217_USD">195541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_4" unitRef="iso4217_USD">757581000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_13" unitRef="iso4217_USD">5609351000</us-gaap:Assets>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_10" unitRef="iso4217_USD">82155000</mpw:StraightLineRentReceivable>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_19" unitRef="iso4217_USD">12831000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_7" unitRef="iso4217_USD">4424354000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_6" unitRef="iso4217_USD">257928000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_9" unitRef="iso4217_USD">46939000</mpw:InterestAndRentReceivable>
  <mpw:OtherLoans contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_11" unitRef="iso4217_USD">664822000</mpw:OtherLoans>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_5" unitRef="iso4217_USD">4682282000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:PayableDueToParentCompany contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_20" unitRef="iso4217_USD">52338000</mpw:PayableDueToParentCompany>
  <mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_3002_2" unitRef="iso4217_USD">3297705000</mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther>
  <us-gaap:CommonUnitIssued contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026_1330097x1333806" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_4002_28" unitRef="shares">234381000</us-gaap:CommonUnitIssued>
  <us-gaap:CommonUnitOutstanding contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026_1330097x1333806" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_4002_29" unitRef="shares">234381000</us-gaap:CommonUnitOutstanding>
  <us-gaap:LimitedPartnersCapitalAccount contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026_1330097x1333806" decimals="-3" id="id_8591822_ADE2D75A-F9E5-4044-83FB-F9723FA04A0C_4002_27" unitRef="iso4217_USD">2153769000</us-gaap:LimitedPartnersCapitalAccount>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1330589_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1003_3" unitRef="iso4217_USD">547085000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1330786_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1007_3" unitRef="iso4217_USD">1031039000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1336058_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1002_3" unitRef="iso4217_USD">1060990000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1336103_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1006_3" unitRef="iso4217_USD">4832596000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1377380_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1004_3" unitRef="iso4217_USD">3047204000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1378289_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1010_3" unitRef="iso4217_USD">1203326000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1402629_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1008_3" unitRef="iso4217_USD">161317000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1529443_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1005_3" unitRef="iso4217_USD">177317000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1529444_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1009_3" unitRef="iso4217_USD">10970000</us-gaap:Assets>
  <us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330926x1328370" decimals="-5" id="id_8591822_37B8B1E6-8B7F-463F-B684-6D3FEF1E062D_1002_0" unitRef="iso4217_USD">1700000</us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1331645x1335058" decimals="-3" id="id_8591822_2F756F51-CABC-4BB4-8E64-37D6F69DEC6B_1001_2" unitRef="iso4217_USD">757581000</us-gaap:LoansReceivableNet>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561" decimals="-3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_1011_3" unitRef="iso4217_USD">6035922000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1393133" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_1004_3" unitRef="iso4217_USD">579182000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1455637" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_1003_3" unitRef="iso4217_USD">1031039000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1491880" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_1002_3" unitRef="iso4217_USD">1032353000</us-gaap:Assets>
  <us-gaap:Assets contextRef="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1531683" decimals="-3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_1005_3" unitRef="iso4217_USD">1059989000</us-gaap:Assets>
  <us-gaap:NumberOfBusinessesAcquired contextRef="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" decimals="INF" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_1001_0" unitRef="Facility">2</us-gaap:NumberOfBusinessesAcquired>
  <us-gaap:DebtInstrumentTerm contextRef="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_1001_6">P10Y</us-gaap:DebtInstrumentTerm>
  <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans contextRef="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" decimals="-6" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_1001_5" unitRef="iso4217_USD">40000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_1001_4">P5Y</mpw:LeaseExtensionPeriod>
  <mpw:LeasePeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_1001_2">P10Y</mpw:LeasePeriod>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460" decimals="INF" id="id_8591822_D2FA2C47-DFD4-46E7-A91C-CFD07BB0F085_1001_3" unitRef="RenewalOptions">2</mpw:NumberOfLeaseExtensionOptions>
  <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="eol_PE631979--1610-Q0008_STD_1_20150227_0_1325953x1439200_1328644x1425879_1330098x1441752_1334994x1393133" decimals="-6" id="id_8591822_6F5402A4-D33A-470E-9732-844E8184EAD4_1001_1" unitRef="iso4217_USD">5000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1610-Q0008_STD_1_20150227_0_1325953x1439200_1328644x1425879_1330098x1441752_1334994x1393133" decimals="-5" id="id_8591822_6F5402A4-D33A-470E-9732-844E8184EAD4_1001_0" unitRef="iso4217_USD">10700000</us-gaap:AcquisitionCosts>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150227_0_1325953x1439200_1328644x1425879_1330098x1441752_1334994x1393133" id="id_8591822_6F5402A4-D33A-470E-9732-844E8184EAD4_1001_3">P5Y</mpw:LeaseExtensionPeriod>
  <mpw:LeasePeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150227_0_1325953x1439200_1328644x1425879_1330098x1441752_1334994x1393133" id="id_8591822_6F5402A4-D33A-470E-9732-844E8184EAD4_1001_2">P20Y</mpw:LeasePeriod>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1610-Q0008_STD_1_20150227_0_1325953x1439200_1328644x1425879_1330098x1441752_1334994x1393133" decimals="INF" id="id_8591822_6F5402A4-D33A-470E-9732-844E8184EAD4_1001_4" unitRef="RenewalOptions">3</mpw:NumberOfLeaseExtensionOptions>
  <us-gaap:GainLossOnSaleOfProperties contextRef="eol_PE631979--1610-Q0008_STD_1_20150805_0_1330098x1336103" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_2002_6" unitRef="iso4217_USD">1700000</us-gaap:GainLossOnSaleOfProperties>
  <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 contextRef="eol_PE631979--1610-Q0008_STD_1_20150805_0_1330098x1336103" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_2002_5" unitRef="iso4217_USD">1500000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE631979--1610-Q0008_STD_1_20150805_0_1330098x1336103" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_2002_1" unitRef="iso4217_USD">9500000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <mpw:BilledRentReceivablesWriteOff contextRef="eol_PE631979--1610-Q0008_STD_1_20150805_0_1330098x1336103" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_2002_7" unitRef="iso4217_USD">900000</mpw:BilledRentReceivablesWriteOff>
  <mpw:NumberOfHospitalsSold contextRef="eol_PE631979--1610-Q0008_STD_1_20150805_0_1330098x1336103" decimals="INF" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_2002_2" unitRef="pure">6</mpw:NumberOfHospitalsSold>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_1_20150811_0_1330096x1487397" decimals="-6" id="id_8591822_827F383D-9FB2-4C8C-A9AB-9FC3C4381AD0_1001_2" unitRef="iso4217_USD">337000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments contextRef="eol_PE631979--1610-Q0008_STD_1_20150811_0_1330096x1487397" decimals="-4" id="id_8591822_827F383D-9FB2-4C8C-A9AB-9FC3C4381AD0_1001_1" unitRef="shares">3750000</mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments>
  <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1 contextRef="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1001_7">2016-09-01</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1001_1">2024-03-01</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667" decimals="5" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1001_4" unitRef="pure">1.06375</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
  <mpw:DebtInstrumentEarliestDateOfRedemption contextRef="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1001_8">2019-03-01</mpw:DebtInstrumentEarliestDateOfRedemption>
  <mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest contextRef="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667" decimals="2" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1001_5" unitRef="pure">1.01</mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest>
  <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667_1335482x1328677" decimals="INF" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_2001_3" unitRef="pure">0.35</us-gaap:DebtInstrumentRedemptionPricePercentage>
  <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates contextRef="eol_PE631979--1610-Q0008_STD_1_20160430_0_1326002x1439614" decimals="-6" id="id_8591822_553ADEB5-E9AF-4AB6-851F-D51A4E555BC3_1_0" unitRef="iso4217_USD">550000000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE631979--1610-Q0008_STD_1_20160430_0_1326002x1439614" decimals="-5" id="id_8591822_553ADEB5-E9AF-4AB6-851F-D51A4E555BC3_1_5" unitRef="iso4217_USD">6300000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:ProceedsFromSaleOfMortgageLoansHeldForSale contextRef="eol_PE631979--1610-Q0008_STD_1_20160430_0_1326002x1439614" decimals="-6" id="id_8591822_553ADEB5-E9AF-4AB6-851F-D51A4E555BC3_1_2" unitRef="iso4217_USD">210000000</us-gaap:ProceedsFromSaleOfMortgageLoansHeldForSale>
  <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans contextRef="eol_PE631979--1610-Q0008_STD_1_20160430_0_1326002x1439614" decimals="-5" id="id_8591822_553ADEB5-E9AF-4AB6-851F-D51A4E555BC3_1_3" unitRef="iso4217_USD">93300000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
  <us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="eol_PE631979--1610-Q0008_STD_1_20160430_0_1326002x1439614" decimals="-6" id="id_8591822_553ADEB5-E9AF-4AB6-851F-D51A4E555BC3_1_1" unitRef="iso4217_USD">492000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1610-Q0008_STD_1_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103" decimals="-6" id="id_8591822_0EE6B9B5-2A62-4E85-B575-5B7C4BCB3A4F_1001_5" unitRef="iso4217_USD">63000000</us-gaap:AcquisitionCosts>
  <mpw:LeasePeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103" id="id_8591822_0EE6B9B5-2A62-4E85-B575-5B7C4BCB3A4F_1001_0">P15Y</mpw:LeasePeriod>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1610-Q0008_STD_1_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103" decimals="INF" id="id_8591822_0EE6B9B5-2A62-4E85-B575-5B7C4BCB3A4F_1001_1" unitRef="RenewalOptions">3</mpw:NumberOfLeaseExtensionOptions>
  <mpw:BusinessCombinationCommitmentPeriodToAdvanceAdditionalAmountForCapitalAdditions contextRef="eol_PE631979--1610-Q0008_STD_1_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103" id="id_8591822_0EE6B9B5-2A62-4E85-B575-5B7C4BCB3A4F_1001_4">P3Y</mpw:BusinessCombinationCommitmentPeriodToAdvanceAdditionalAmountForCapitalAdditions>
  <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations contextRef="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494" decimals="-6" id="id_8591822_EF088786-B164-45EA-A18F-E1D1503E3D60_1_5" unitRef="iso4217_USD">15000000</us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations>
  <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494" decimals="-6" id="id_8591822_EF088786-B164-45EA-A18F-E1D1503E3D60_1_3" unitRef="iso4217_USD">4000000</us-gaap:RepaymentsOfRelatedPartyDebt>
  <us-gaap:ProceedsFromSaleOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494" decimals="-6" id="id_8591822_EF088786-B164-45EA-A18F-E1D1503E3D60_1_4" unitRef="iso4217_USD">71000000</us-gaap:ProceedsFromSaleOfRealEstate>
  <mpw:NumberOfPropertiesSold contextRef="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494" decimals="INF" id="id_8591822_EF088786-B164-45EA-A18F-E1D1503E3D60_1_0" unitRef="Property">5</mpw:NumberOfPropertiesSold>
  <mpw:NumberOfPropertiesSold contextRef="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494_1330098x1328464" decimals="INF" id="id_8591822_EF088786-B164-45EA-A18F-E1D1503E3D60_1001_2" unitRef="Property">2</mpw:NumberOfPropertiesSold>
  <mpw:NumberOfPropertiesSold contextRef="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494_1330098x1336058" decimals="INF" id="id_8591822_EF088786-B164-45EA-A18F-E1D1503E3D60_2001_1" unitRef="Property">3</mpw:NumberOfPropertiesSold>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE631979--1610-Q0008_STD_1_20120301_0" decimals="-5" id="id_8591822_9D351586-B445-4CE8-B6CE-50C02964D7E2_1_0" unitRef="iso4217_USD">1700000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <mpw:PercentageOfEquitySharesFromConvertibleDebt contextRef="eol_PE631979--1610-Q0008_STD_1_20120301_0" decimals="INF" id="id_8591822_9D351586-B445-4CE8-B6CE-50C02964D7E2_1_2" unitRef="pure">0.099</mpw:PercentageOfEquitySharesFromConvertibleDebt>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1610-Q0008_STD_1_20150429_0_1325953x1439200_1326002x1455637" decimals="-6" id="id_8591822_6B676F8A-6517-4ED7-8355-E4A59664FC4A_1002_1" unitRef="iso4217_EUR">688000000</us-gaap:AcquisitionCosts>
  <mpw:NumberOfHospitalsAcquired contextRef="eol_PE631979--1610-Q0008_STD_1_20150429_0_1325953x1439200_1326002x1455637" decimals="INF" id="id_8591822_6B676F8A-6517-4ED7-8355-E4A59664FC4A_1001_0" unitRef="Hospital">32</mpw:NumberOfHospitalsAcquired>
  <mpw:LeaseAgreementAnnualIncrementalInterestPercentage contextRef="eol_PE631979--1610-Q0008_STD_1_20150429_0_1325953x1439200_1326002x1455637" decimals="2" id="id_8591822_6B676F8A-6517-4ED7-8355-E4A59664FC4A_1001_3" unitRef="pure">0.70</mpw:LeaseAgreementAnnualIncrementalInterestPercentage>
  <mpw:LeasePeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150429_0_1325953x1439200_1326002x1455637" id="id_8591822_6B676F8A-6517-4ED7-8355-E4A59664FC4A_1001_2">P27Y</mpw:LeasePeriod>
  <mpw:SalesCommission contextRef="eol_PE631979--1610-Q0008_STD_1_20160301_0_1334258x1485840" decimals="4" id="id_8591822_3993D3D3-516B-46AA-B646-C6ACB3E36F13_1_1" unitRef="pure">0.0125</mpw:SalesCommission>
  <mpw:NumberOfBedsAcquired contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1328644x1358103_1334994x1393133" decimals="INF" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_1001_2" unitRef="Bed">37</mpw:NumberOfBedsAcquired>
  <mpw:NumberOfBedsAcquired contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1328644x1366429_1334994x1393133" decimals="INF" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_2001_1" unitRef="Bed">60</mpw:NumberOfBedsAcquired>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1334994x1393133" decimals="-5" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_3001_3" unitRef="iso4217_USD">31500000</us-gaap:AcquisitionCosts>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1334994x1393133" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_3001_6">P5Y</mpw:LeaseExtensionPeriod>
  <mpw:NumberOfRealEstatePropertiesAcquired contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1334994x1393133" decimals="INF" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_3001_0" unitRef="Property">2</mpw:NumberOfRealEstatePropertiesAcquired>
  <mpw:LeasePeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1334994x1393133" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_3001_4">P20Y</mpw:LeasePeriod>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1334994x1393133" decimals="INF" id="id_8591822_1EC6212E-1C7E-4755-B649-74350D8C3DB2_3001_5" unitRef="RenewalOptions">3</mpw:NumberOfLeaseExtensionOptions>
  <us-gaap:GainLossOnSaleOfProperties contextRef="eol_PE631979--1610-Q0008_STD_1_20150730_0_1330098x1336058" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_1001_3" unitRef="iso4217_USD">1500000</us-gaap:GainLossOnSaleOfProperties>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE631979--1610-Q0008_STD_1_20150730_0_1330098x1336058" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_1001_0" unitRef="iso4217_USD">9700000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <mpw:StraightLineRentReceivablesWriteOff contextRef="eol_PE631979--1610-Q0008_STD_1_20150730_0_1330098x1336058" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_1001_4" unitRef="iso4217_USD">900000</mpw:StraightLineRentReceivablesWriteOff>
  <us-gaap:GainLossOnSaleOfProperties contextRef="eol_PE631979--1610-Q0008_STD_1_20160617_0_1326002x1529494" decimals="-6" id="id_8591822_14D9F7D8-8B06-40B9-BEA9-4279239E7946_1_1" unitRef="iso4217_USD">8000000</us-gaap:GainLossOnSaleOfProperties>
  <us-gaap:ProceedsFromSaleOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_1_20160617_0_1326002x1529494" decimals="-6" id="id_8591822_14D9F7D8-8B06-40B9-BEA9-4279239E7946_1_0" unitRef="iso4217_USD">28000000</us-gaap:ProceedsFromSaleOfRealEstate>
  <mpw:DisposalGroupIncludingDiscontinuedOperationLossGainOnWriteDown contextRef="eol_PE631979--1610-Q0008_STD_1_20160617_0_1326002x1529494_1330098x1336058" decimals="-6" id="id_8591822_14D9F7D8-8B06-40B9-BEA9-4279239E7946_1001_2" unitRef="iso4217_USD">9000000</mpw:DisposalGroupIncludingDiscontinuedOperationLossGainOnWriteDown>
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="eol_PE631979--1610-Q0008_STD_1_20160622_0_1325953x1430282_1330098x1535290_1333690x1439614" decimals="-6" id="id_8591822_8DB70BE6-F140-4439-89E0-A78388D3B79C_1001_1" unitRef="iso4217_EUR">7000000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations contextRef="eol_PE631979--1610-Q0008_STD_1_20160720_0_1326002x1531688" decimals="-6" id="id_8591822_0D8CFA72-E9C5-4E0E-B3E8-49D668DFC761_1_2" unitRef="iso4217_USD">45000000</us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations>
  <us-gaap:ProceedsFromSaleOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_1_20160720_0_1326002x1531688" decimals="-5" id="id_8591822_0D8CFA72-E9C5-4E0E-B3E8-49D668DFC761_1_1" unitRef="iso4217_USD">111500000</us-gaap:ProceedsFromSaleOfRealEstate>
  <mpw:NumberOfHospitalsSold contextRef="eol_PE631979--1610-Q0008_STD_1_20160720_0_1326002x1531688_1330098x1336058" decimals="INF" id="id_8591822_0D8CFA72-E9C5-4E0E-B3E8-49D668DFC761_1001_0" unitRef="Hospital">3</mpw:NumberOfHospitalsSold>
  <mpw:NumberOfRehabilitationHospitals contextRef="eol_PE631979--1610-Q0008_STD_1_20160720_0_1330098x1330786" decimals="INF" id="id_8591822_6FC8D2AE-1221-469D-9861-F292BACBB867_1001_0" unitRef="Hospital">23</mpw:NumberOfRehabilitationHospitals>
  <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1 contextRef="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1001_2">2017-02-01</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1001_4">2026-08-01</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691" decimals="4" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1001_8" unitRef="pure">1.0525</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
  <mpw:DebtInstrumentEarliestDateOfRedemption contextRef="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1001_5">2021-08-01</mpw:DebtInstrumentEarliestDateOfRedemption>
  <mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest contextRef="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691" decimals="2" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1001_9" unitRef="pure">1.01</mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest>
  <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691_1335482x1328677" decimals="INF" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_2001_7" unitRef="pure">0.35</us-gaap:DebtInstrumentRedemptionPricePercentage>
  <mpw:NumberOfBedsAcquired contextRef="eol_PE631979--1610-Q0008_STD_1_20150831_0_1325953x1439200_1328644x1502927_1334994x1519445" decimals="INF" id="id_8591822_704D825B-629C-4EE1-A3E0-D09FD026CA89_1001_1" unitRef="Bed">144</mpw:NumberOfBedsAcquired>
  <us-gaap:DebtInstrumentTerm contextRef="eol_PE631979--1610-Q0008_STD_1_20150831_0_1325953x1439200_1334994x1519445" id="id_8591822_704D825B-629C-4EE1-A3E0-D09FD026CA89_2001_2">P5Y</us-gaap:DebtInstrumentTerm>
  <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans contextRef="eol_PE631979--1610-Q0008_STD_1_20150831_0_1325953x1439200_1334994x1519445" decimals="-6" id="id_8591822_704D825B-629C-4EE1-A3E0-D09FD026CA89_2001_0" unitRef="iso4217_USD">30000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
  <mpw:EstimatedDevelopmentCosts contextRef="eol_PE631979--1610-Q0008_STD_1_20150909_0_1325953x1439200_1328480x1409831_1328644x1358103_1330098x1334274" decimals="-5" id="id_8591822_E8D2B178-D6A0-4DDE-9BA4-83961E86A22B_1001_0" unitRef="iso4217_EUR">21400000</mpw:EstimatedDevelopmentCosts>
  <mpw:NumberOfPropertiesClosedOn contextRef="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1326002x1455637" decimals="INF" id="id_8591822_69DE2CF8-45DC-414B-B356-81CCD004A5AA_1001_0" unitRef="Property">30</mpw:NumberOfPropertiesClosedOn>
  <us-gaap:DebtInstrumentTerm contextRef="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1328644x1440213" id="id_8591822_398CC972-2379-45F3-BEB8-482EA59390E0_1001_3">P5Y</us-gaap:DebtInstrumentTerm>
  <us-gaap:MortgageLoansOnRealEstateCollectionsOfPrincipal contextRef="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1328644x1440213" decimals="-6" id="id_8591822_398CC972-2379-45F3-BEB8-482EA59390E0_1001_4" unitRef="iso4217_USD">85000000</us-gaap:MortgageLoansOnRealEstateCollectionsOfPrincipal>
  <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans contextRef="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1328644x1440213" decimals="-6" id="id_8591822_398CC972-2379-45F3-BEB8-482EA59390E0_1001_0" unitRef="iso4217_USD">100000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
  <mpw:NumberOfLicensedHospitals contextRef="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1328644x1440213" decimals="INF" id="id_8591822_398CC972-2379-45F3-BEB8-482EA59390E0_1001_1" unitRef="Hospital">3</mpw:NumberOfLicensedHospitals>
  <mpw:NumberOfFreeStandingEmergencyDepartmentAndHealthCenter contextRef="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1328644x1440213" decimals="INF" id="id_8591822_398CC972-2379-45F3-BEB8-482EA59390E0_1001_2" unitRef="Hospital">1</mpw:NumberOfFreeStandingEmergencyDepartmentAndHealthCenter>
  <mpw:NumberOfRehabilitationHospitals contextRef="eol_PE631979--1610-Q0008_STD_1_20160909_0_1330098x1330786" decimals="INF" id="id_8591822_D5F8F3A9-193B-4491-8B17-5ACC27399C3D_1001_0" unitRef="Hospital">6</mpw:NumberOfRehabilitationHospitals>
  <mpw:NumberOfRehabilitationHospitals contextRef="eol_PE631979--1610-Q0008_STD_1_20160928_0_1330098x1534851" decimals="INF" id="id_8591822_ECB6E727-76BC-4170-8359-8AF036C61305_1001_0" unitRef="Hospital">2</mpw:NumberOfRehabilitationHospitals>
  <mpw:NumberOfRehabilitationHospitalsClosed contextRef="eol_PE631979--1610-Q0008_STD_1_20161001_0_1330098x1330786_1335955x1330134" decimals="INF" id="id_8591822_D5F8F3A9-193B-4491-8B17-5ACC27399C3D_2003_2" unitRef="Facility">3</mpw:NumberOfRehabilitationHospitalsClosed>
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="-6" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_1001_3" unitRef="iso4217_USD">600000000</us-gaap:PaymentsToAcquireBusinessesGross>
  <mpw:NumberOfLicensedHospitals contextRef="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="INF" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_1001_2" unitRef="Hospital">5</mpw:NumberOfLicensedHospitals>
  <mpw:LeasePeriod contextRef="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_1001_6">P15Y</mpw:LeasePeriod>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="INF" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_1001_7" unitRef="RenewalOptions">3</mpw:NumberOfLeaseExtensionOptions>
  <mpw:NumberOfHospitalsClosed contextRef="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="INF" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_1001_0" unitRef="Hospital">9</mpw:NumberOfHospitalsClosed>
  <mpw:BusinessCombinationEquityInterestInAcquireeFairValue contextRef="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134" decimals="-6" id="id_8591822_2F000A57-4D1E-4F7E-A3BE-F3138D5B5B56_1001_5" unitRef="iso4217_USD">50000000</mpw:BusinessCombinationEquityInterestInAcquireeFairValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE631979--1610-Q0008_STD_1_20161007_0_1326002x1433225_1330097x1333806_1330125x1329075_1335955x1330134" decimals="-5" id="id_8591822_7AFE1339-3B89-4639-8265-28FB47C5A04B_1001_0" unitRef="shares">10300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_1_20161007_0_1326002x1433225_1330097x1333806_1330125x1329075_1335955x1330134" decimals="-6" id="id_8591822_7AFE1339-3B89-4639-8265-28FB47C5A04B_1001_2" unitRef="iso4217_USD">150000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_1_20150114_0_1330096x1487397" decimals="-6" id="id_8591822_86320518-3EA8-4DA3-BB20-E0F7881CEEC0_1001_2" unitRef="iso4217_USD">480000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments contextRef="eol_PE631979--1610-Q0008_STD_1_20150114_0_1330096x1487397" decimals="-5" id="id_8591822_86320518-3EA8-4DA3-BB20-E0F7881CEEC0_1001_1" unitRef="shares">4500000</mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments>
  <mpw:NumberOfHospitalsOwned contextRef="eol_PE631979--1610-Q0008_STD_182_20160630_0_1326002x1439614" decimals="INF" id="id_8591822_240DF095-F001-41FE-9CF4-4E99D01BAAB7_1_0" unitRef="Hospital">5</mpw:NumberOfHospitalsOwned>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_35" unitRef="iso4217_USD_per_shares">0.38</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_33" unitRef="iso4217_USD_per_shares">0.38</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_8" unitRef="shares">212068000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_6" unitRef="shares">211659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_28" unitRef="iso4217_USD_per_shares">0.38</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_4_2" unitRef="iso4217_USD_per_shares">0.71</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="INF" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_37" unitRef="iso4217_USD_per_shares">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_30" unitRef="iso4217_USD_per_shares">0.38</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_7" unitRef="shares">409000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_16" unitRef="iso4217_USD">132184000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_5" unitRef="iso4217_USD">310333000</us-gaap:Revenues>
  <us-gaap:PaymentsForProceedsFromLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_21" unitRef="iso4217_USD">354002000</us-gaap:PaymentsForProceedsFromLoansReceivable>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_4_3" unitRef="iso4217_USD">-39859000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_4" unitRef="iso4217_USD">77924000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_4_0" unitRef="iso4217_USD">13598000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_4_4" unitRef="iso4217_USD">11748000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_42" unitRef="iso4217_USD">83000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_4" unitRef="iso4217_USD">17815000</us-gaap:StraightLineRent>
  <us-gaap:PaymentsToAcquireOtherInvestments contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_25" unitRef="iso4217_USD">9803000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_31" unitRef="iso4217_USD">130841000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_13" unitRef="iso4217_USD">168675000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_26" unitRef="iso4217_USD">81361000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_40" unitRef="iso4217_USD">74911000</us-gaap:InterestPaid>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_16" unitRef="iso4217_USD">3268000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_4_4" unitRef="iso4217_USD">43772000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_4_6" unitRef="iso4217_USD">43544000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_3" unitRef="iso4217_USD">40055000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_30" unitRef="iso4217_USD">210000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_24" unitRef="iso4217_USD">81589000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_0" unitRef="iso4217_USD">81589000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_9" unitRef="iso4217_USD">3268000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_4_1" unitRef="iso4217_USD">227000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_18" unitRef="iso4217_USD">2020198000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_19" unitRef="iso4217_USD">-2488000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_12" unitRef="iso4217_USD">265000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_4_2" unitRef="iso4217_USD">2042000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_21" unitRef="iso4217_USD">-87086000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_4_0" unitRef="iso4217_USD">480100</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_3" unitRef="iso4217_USD">51149000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_1" unitRef="iso4217_USD">228000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_20" unitRef="iso4217_USD">1018000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_15" unitRef="iso4217_USD">84961000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_32" unitRef="iso4217_USD">817533000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_8" unitRef="iso4217_USD">8383000</us-gaap:ShareBasedCompensation>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_10" unitRef="iso4217_USD">56997000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_7" unitRef="iso4217_USD">49728000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_9" unitRef="iso4217_USD">2608000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ImpairmentOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_5" unitRef="iso4217_USD">2812000</us-gaap:ImpairmentOfRealEstate>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_26" unitRef="iso4217_USD">-1782488000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_34" unitRef="iso4217_USD">-7950000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_10" unitRef="iso4217_USD">4293000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_12" unitRef="iso4217_USD">141658000</us-gaap:CostsAndExpenses>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_37" unitRef="iso4217_USD">-5157000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_11" unitRef="iso4217_USD">32325000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_25" unitRef="iso4217_USD">228000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_20" unitRef="iso4217_USD">698040000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_28" unitRef="iso4217_USD">500415000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_36" unitRef="iso4217_USD">192851000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_4_5" unitRef="iso4217_USD">228000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_4_1" unitRef="iso4217_USD">2846000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_15" unitRef="iso4217_USD">11744000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_35" unitRef="iso4217_USD">1843155000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_29" unitRef="iso4217_USD">676877000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_19" unitRef="iso4217_USD">19175000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_3" unitRef="iso4217_USD">80580000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_33" unitRef="iso4217_USD">12669000</mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_14" unitRef="iso4217_USD">5471000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_17" unitRef="iso4217_USD">4319000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_5" unitRef="iso4217_USD">80580000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_4_3" unitRef="iso4217_USD">1078000</mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_1" unitRef="iso4217_USD">177351000</mpw:RentBilled>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_22" unitRef="iso4217_USD">115700000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_2_2" unitRef="iso4217_USD">781000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_2_7" unitRef="iso4217_USD">5286000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_18" unitRef="iso4217_USD">2432000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:DisposalGroupIncludingDiscontinuedOperationPropertyRelatedExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_4_2" unitRef="iso4217_USD">82000</mpw:DisposalGroupIncludingDiscontinuedOperationPropertyRelatedExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_4_2" unitRef="iso4217_USD">15003000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1324199x1329007" decimals="INF" id="id_8591822_CC1B62DE-3832-4F70-B5A5-4504CF5B0DD3_1002_0" unitRef="shares">366838</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1324199x1451778" decimals="INF" id="id_8591822_0A483B33-E685-4786-B346-9E661E671C20_1002_0" unitRef="shares">505050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1324199x1458258" decimals="INF" id="id_8591822_64DEC6DC-1FF1-4C52-80D4-9424CA66D632_1002_0" unitRef="shares">407969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1325953x1439200_1333690x1500705" decimals="-5" id="id_8591822_7E0DF3BD-5272-4E0F-839E-92B5749D6472_1002_0" unitRef="iso4217_USD">59200000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1325953x1439200_1333690x1500705" decimals="-5" id="id_8591822_7E0DF3BD-5272-4E0F-839E-92B5749D6472_1002_2" unitRef="iso4217_USD">52900000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <mpw:OperatingLeasesIncomeStatementLeaseIncome contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1325953x1439200_1333690x1500705" decimals="-5" id="id_8591822_7E0DF3BD-5272-4E0F-839E-92B5749D6472_1002_1" unitRef="iso4217_USD">34300000</mpw:OperatingLeasesIncomeStatementLeaseIncome>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_35" unitRef="iso4217_USD_per_shares">0.38</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_33" unitRef="iso4217_USD_per_shares">0.38</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_8" unitRef="shares">212068000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_6" unitRef="shares">211659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_28" unitRef="iso4217_USD_per_shares">0.38</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="INF" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_37" unitRef="iso4217_USD_per_shares">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_30" unitRef="iso4217_USD_per_shares">0.38</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_7" unitRef="shares">409000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_16" unitRef="iso4217_USD">132184000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PartnersCapitalAccountUnitsSaleOfUnits contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-4" id="id_8591822_435CBC63-694B-496A-8248-2F3D0A23379B_1002_0" unitRef="shares">63250000</us-gaap:PartnersCapitalAccountUnitsSaleOfUnits>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_5" unitRef="iso4217_USD">310333000</us-gaap:Revenues>
  <us-gaap:PaymentsForProceedsFromLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_21" unitRef="iso4217_USD">354002000</us-gaap:PaymentsForProceedsFromLoansReceivable>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1004_3" unitRef="iso4217_USD">-39859000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_4" unitRef="iso4217_USD">77924000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_42" unitRef="iso4217_USD">83000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_4" unitRef="iso4217_USD">17815000</us-gaap:StraightLineRent>
  <us-gaap:PaymentsToAcquireOtherInvestments contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_25" unitRef="iso4217_USD">9803000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_31" unitRef="iso4217_USD">130841000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_13" unitRef="iso4217_USD">168675000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_26" unitRef="iso4217_USD">81361000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_40" unitRef="iso4217_USD">74911000</us-gaap:InterestPaid>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_16" unitRef="iso4217_USD">3268000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1004_4" unitRef="iso4217_USD">43772000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1004_6" unitRef="iso4217_USD">43544000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_3" unitRef="iso4217_USD">40055000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_30" unitRef="iso4217_USD">210000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_24" unitRef="iso4217_USD">81589000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_0" unitRef="iso4217_USD">81589000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_9" unitRef="iso4217_USD">3268000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_18" unitRef="iso4217_USD">2020198000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_19" unitRef="iso4217_USD">-2488000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_12" unitRef="iso4217_USD">265000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1004_2" unitRef="iso4217_USD">2042000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_21" unitRef="iso4217_USD">-87086000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_3" unitRef="iso4217_USD">51149000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_1" unitRef="iso4217_USD">228000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_20" unitRef="iso4217_USD">1018000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_15" unitRef="iso4217_USD">84961000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_32" unitRef="iso4217_USD">817533000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_8" unitRef="iso4217_USD">8383000</us-gaap:ShareBasedCompensation>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_10" unitRef="iso4217_USD">56997000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_7" unitRef="iso4217_USD">49728000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_9" unitRef="iso4217_USD">2608000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ImpairmentOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_5" unitRef="iso4217_USD">2812000</us-gaap:ImpairmentOfRealEstate>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_26" unitRef="iso4217_USD">-1782488000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_34" unitRef="iso4217_USD">-7950000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_10" unitRef="iso4217_USD">4293000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_12" unitRef="iso4217_USD">141658000</us-gaap:CostsAndExpenses>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_37" unitRef="iso4217_USD">-5157000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_11" unitRef="iso4217_USD">32325000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_25" unitRef="iso4217_USD">228000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_20" unitRef="iso4217_USD">698040000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_28" unitRef="iso4217_USD">500415000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_36" unitRef="iso4217_USD">192851000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1004_5" unitRef="iso4217_USD">228000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_15" unitRef="iso4217_USD">11744000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_35" unitRef="iso4217_USD">1843155000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_29" unitRef="iso4217_USD">676877000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_19" unitRef="iso4217_USD">19175000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_3" unitRef="iso4217_USD">80580000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_33" unitRef="iso4217_USD">12669000</mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_14" unitRef="iso4217_USD">5471000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_17" unitRef="iso4217_USD">4319000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_5" unitRef="iso4217_USD">80580000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_1" unitRef="iso4217_USD">177351000</mpw:RentBilled>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_22" unitRef="iso4217_USD">115700000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1002_2" unitRef="iso4217_USD">781000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1002_7" unitRef="iso4217_USD">5286000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_18" unitRef="iso4217_USD">2432000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1004_2" unitRef="iso4217_USD">15003000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1330589_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1002_4" unitRef="pure">0.160</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1330589_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1002_3" unitRef="iso4217_USD">49595000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1330786_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1005_4" unitRef="pure">0.182</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1330786_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1005_3" unitRef="iso4217_USD">56609000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1336058_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1001_4" unitRef="pure">0.206</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1336058_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1001_3" unitRef="iso4217_USD">63815000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1336103_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1004_4" unitRef="pure">0.807</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1336103_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1004_3" unitRef="iso4217_USD">250416000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1377380_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1003_4" unitRef="pure">0.441</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1377380_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1003_3" unitRef="iso4217_USD">137006000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1378289_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1007_4" unitRef="pure">0.193</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1378289_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1007_3" unitRef="iso4217_USD">59917000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1402629_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1006_4" unitRef="pure">0.011</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1402629_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1006_3" unitRef="iso4217_USD">3308000</us-gaap:Revenues>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330926x1328370" decimals="INF" id="id_8591822_5F3CFCB6-C580-4E87-8429-24B2A6D3A6FB_1004_0" unitRef="iso4217_USD">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561" decimals="INF" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1008_4" unitRef="pure">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_1008_3" unitRef="iso4217_USD">310333000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1393133" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1003_4" unitRef="pure">0.148</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1393133" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1003_3" unitRef="iso4217_USD">45874000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1412130" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1005_4" unitRef="pure">0.042</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1412130" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1005_3" unitRef="iso4217_USD">12982000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1455637" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1002_4" unitRef="pure">0.182</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1455637" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1002_3" unitRef="iso4217_USD">56609000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1491880" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1001_4" unitRef="pure">0.245</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1491880" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1001_3" unitRef="iso4217_USD">75982000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1531683" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1004_4" unitRef="pure">0.023</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1531683" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_1004_3" unitRef="iso4217_USD">7155000</us-gaap:Revenues>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="eol_PE631979--1610-Q0008_STD_273_20150930_0_1335427x1487449" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_1002_3">P28Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_BE8C16D0-275D-4A23-A665-9D1855863DA8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;9. Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;i&gt;Commitments&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"&gt;
 On July 20, 2016, we entered into definitive agreements to acquire
 23 rehabilitation hospitals in Germany for an aggregate purchase
 price to us of approximately &amp;#x20AC;215.7 million. Upon closing,
 the facilities will be leased to affiliates of MEDIAN, pursuant to
 a long-term master lease. Closing of the transaction, which is
 expected to begin during the fourth quarter of 2016, is subject to
 customary real estate, regulatory and other closing conditions.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 8%"&gt;
 On September 9, 2016, we entered into definitive agreements to
 acquire six rehabilitation hospitals in Germany for an aggregate
 purchase price to us of approximately &amp;#x20AC;46.3 million. Upon
 closing, the facilities will be leased to affiliates of MEDIAN,
 pursuant to a long-term master lease. Closing of the transaction,
 which is expected during the fourth quarter of 2016, is subject to
 customary real estate, regulatory and other closing
 conditions.&amp;#xA0;Subsequent to September 30, 2016, we closed on
 three of the six facilities in the amount of &amp;#x20AC;22.9
 million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"&gt;
 On September 28, 2016, we entered into definitive agreements to
 acquire two acute care hospitals in Washington and Idaho for an
 aggregate purchase price to us of approximately $105 million. Upon
 closing, the facilities will be leased to RCCH, pursuant to the
 current master lease. Closing of the transaction, which is expected
 to be completed by the first quarter of 2017, is subject to
 customary real estate, regulatory and other closing conditions.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Contingencies&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"&gt;
 We are a party to various legal proceedings incidental to our
 business. In the opinion of management, after consultation with
 legal counsel, the ultimate liability, if any, with respect to
 those proceedings is not presently expected to materially affect
 our financial position, results of operations or cash flows.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_D76BAF83-8265-4E83-8C24-32077CF70FC1_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;6. Stock Awards&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We adopted the 2013 Equity Incentive Plan (the &amp;#x201C;Equity
 Incentive Plan&amp;#x201D;) during the second quarter of 2013, which
 authorizes the issuance of common stock options, restricted stock,
 restricted stock units, deferred stock units, stock appreciation
 rights, performance units and awards of interests in our Operating
 Partnership. The Equity Incentive Plan is administered by the
 Compensation Committee of the Board of Directors. We have reserved
 8,196,770 shares of common stock for awards under the Equity
 Incentive Plan for which 4,763,066 shares remain available for
 future stock awards as of September&amp;#xA0;30, 2016. We awarded the
 following stock awards during 2016 and 2015:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 62px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Time-based awards&amp;#xA0;&lt;/i&gt;&amp;#x2014;We granted 254,574
 and 407,969 shares in 2016 and 2015, respectively, of time-based
 restricted stock. These awards generally vest quarterly based on
 service, over three years, in equal amounts.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 62px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Performance-based awards&amp;#xA0;&lt;/i&gt;&amp;#x2014;We awarded 366,838
 shares of performance based awards in 2015. No such awards have
 been granted in 2016. These awards vest ratably over a three-year
 period based on the achievement of certain total shareholder return
 measures, with a carry-back and carry-forward provision through
 December&amp;#xA0;31, 2017. Dividends on these awards are paid only
 upon achievement of the performance measures.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 62px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Multi-year Performance-based awards&amp;#xA0;&lt;/i&gt;&amp;#x2014;We awarded 799,804
 and 505,050 shares in 2016 and 2015, respectively, of multi-year
 performance-based awards. These shares are subject to three-year
 cumulative performance hurdles based on measures of total
 shareholder return. At the end of the three-year performance
 period, any earned shares will be subject to an additional two
 years of ratable time-based vesting on an annual basis. Dividends
 are paid on these shares only upon achievement of the performance
 measures.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1_4">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1_3">2016</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1_0">10-Q</dei:DocumentType>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_35" unitRef="iso4217_USD_per_shares">0.75</us-gaap:EarningsPerShareDiluted>
  <dei:EntityCentralIndexKey contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1_2">0001287865</dei:EntityCentralIndexKey>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="2" id="id_8591822_5FE36531-4C64-4AAC-8C55-593803FD35CC_1_0" unitRef="pure">0.40</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_33" unitRef="iso4217_USD_per_shares">0.75</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_719D744F-AFC7-41F6-82B1-1AC268241E22_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 &lt;i&gt;Recent Accounting Developments:&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; MARGIN-LEFT: 151px; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 In May 2014, the Financial Accounting Standards Board
 (&amp;#x201C;FASB&amp;#x201D;) issued Accounting Standards Update
 (&amp;#x201C;ASU&amp;#x201D;) No. 2014-09,&amp;#xA0;&lt;i&gt;Revenue from Contracts with
 Customers&lt;/i&gt;. Under the new standard, revenue is recognized at the
 time a good or service is transferred to a customer for the amount
 of consideration received for that specific good or service.
 Entities may use a full retrospective approach or report the
 cumulative effect as of the date of adoption. On April 1, 2015, the
 FASB proposed deferring the effective date of this standard by one
 year to December 15, 2017, for annual reporting periods beginning
 after that date. The FASB also proposed permitting early adoption
 of the standard, but not before the original effective date of
 December 15, 2016. We are continuing to evaluate this standard;
 however, we do not expect it to have a significant impact on our
 financial results, as a substantial portion of our revenue consists
 of rental income from leasing arrangements, which are specifically
 excluded from ASU No. 2014-09.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; MARGIN-LEFT: 151px; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 &lt;i&gt;Leases&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 In February 2016, the FASB issued
 ASU&amp;#xA0;2016-02&amp;#xA0;-&amp;#xA0;&lt;i&gt;Leases&lt;/i&gt;, which sets out the
 principles for the recognition, measurement, presentation and
 disclosure of leases for both parties to a contract (i.e. lessees
 and lessors).&amp;#xA0;The new standard requires lessees to apply a
 dual approach, classifying leases as either financing or operating
 leases based on the principle of whether or not the lease is
 effectively a financed purchase by the lessee.&amp;#xA0;This
 classification will determine&amp;#xA0;whether lease expense is
 recognized&amp;#xA0;based on an effective interest
 method&amp;#xA0;or&amp;#xA0;on a straight line basis over the term of the
 lease.&amp;#xA0;A lessee is also required to record a right-of-use
 asset and a lease liability for all leases with a term of greater
 than 12 months regardless of their classification.&amp;#xA0;Leases with
 a term of 12 months or less will be accounted for similar to
 existing guidance for operating leases today. The new standard
 requires lessors to account for leases using an approach that is
 substantially equivalent to existing guidance for sales-type
 leases, direct financing leases and operating leases. The ASU is
 not effective for us until January&amp;#xA0;1, 2019 with early adoption
 permitted. We are continuing to evaluate this standard and the
 impact to us from both a lessor and a lessee perspective.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; MARGIN-LEFT: 151px; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 &lt;i&gt;Measurement of Credit Losses on Financial Instruments&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 In June 2016, the FASB issued ASU 2016-13,&amp;#xA0;&lt;i&gt;Measurement of Credit
 Losses on Financial Instruments&lt;/i&gt;, which is intended to improve
 financial reporting by requiring timely recording of credit losses
 on loans and other financial instruments held by financial
 institutions and other organizations.&amp;#xA0;The ASU requires the
 measurement of all expected credit losses for financial assets not
 recorded at fair value based on historical experience, current
 conditions, and reasonable and supportable forecasts.&amp;#xA0;The ASU
 will be required to be implemented through a cumulative-effect
 adjustment to retained earnings as of the beginning of the first
 reporting period in which the amendments are effective.&amp;#xA0;The
 ASU is not effective for us until January 1, 2019. We do not expect
 the adoption of this ASU to have a significant impact on our
 consolidated financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; MARGIN-LEFT: 151px; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 &lt;i&gt;Classification of Certain Cash Receipts and Cash
 Payments&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"&gt;
 In August 2016, the FASB issued ASU No. 2016-15,&amp;#xA0;&lt;i&gt;Classification of Certain
 Cash Receipts and Cash Payments&lt;/i&gt;, which clarifies the
 classification within the statement of cash flows for certain
 transactions, including debt extinguishment costs, zero-coupon
 debt, contingent consideration related to business combinations,
 insurance proceeds, equity method distributions and beneficial
 interests in securitizations. The standard also clarifies that cash
 flows with aspects of multiple classes of cash flows or that cannot
 be separated by source or use should be classified based on the
 activity that is likely to be the predominant source or use of cash
 flows for the item. This guidance is effective for us starting
 January 1, 2018.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:PartnersCapitalNotesDisclosureTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_9CF590BF-8A89-488C-ABD2-925762EC97EC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;5. Common Stock/Partners&amp;#x2019; Capital&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Medical Properties Trust, Inc.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On October 7, 2016, we sold 10.3 million shares of common stock in
 a private placement with an affiliate of Cerberus Capital
 Management (&amp;#x201C;Cerberus&amp;#x201D;), the controlling member of
 Steward.&amp;#xA0;We sold these shares at a price per share of $14.50,
 equal to the public offering price of our September 2016 equity
 offering, generating total proceeds of approximately $150
 million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On September 30, 2016, we completed an underwritten public offering
 of 57.5 million shares (including the exercise of the
 underwriters&amp;#x2019; 30-day option to purchase an additional
 7.5&amp;#xA0;million shares) of our common stock, resulting in net
 proceeds of $799.5 million, after deducting estimated offering
 expenses.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On March&amp;#xA0;1, 2016, we updated our at-the-market equity offering
 program, which gave us the ability to sell up to $227 million of
 stock with a commission rate of 1.25%. During the nine months ended
 September&amp;#xA0;30, 2016, we sold approximately 15&amp;#xA0;million
 shares of our common stock under this program, resulting in net
 proceeds of approximately $224 million, after deducting
 approximately $2.8 million of commissions.&amp;#xA0;We have no capacity
 to sell additional shares under this at-the-market equity offering
 program.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On August&amp;#xA0;11, 2015, we completed an underwritten public
 offering of 28.75&amp;#xA0;million shares (including the exercise of
 the underwriters&amp;#x2019; 30-day option to purchase an additional
 3.75 million shares) of our common stock, resulting in net proceeds
 of $337 million, after deducting estimated offering expenses.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On January&amp;#xA0;14, 2015, we completed an underwritten public
 offering of 34.5&amp;#xA0;million shares (including the exercise of the
 underwriters&amp;#x2019; 30-day option to purchase an additional
 4.5&amp;#xA0;million shares) of our common stock, resulting in net
 proceeds of approximately $480 million, after deducting estimated
 offering expenses.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;MPT Operating Partnership, L.P.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 At September&amp;#xA0;30, 2016, the Company has a 99.87% ownership
 interest in the Operating Partnership with the remainder owned by
 three other partners, two of whom are employees and one of whom is
 a director. During the nine months ended September&amp;#xA0;30, 2016
 and 2015, the Operating Partnership issued 72.5 million units and
 63.25&amp;#xA0;million units, respectively, in direct response to the
 common stock offerings by Medical Properties Trust, Inc.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:PartnersCapitalNotesDisclosureTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_2537B978-A234-4E0E-99D1-F8440A895767_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We acquired the following assets (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;Nine&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Assets Acquired&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Land and land improvements&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13,874&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;113,309&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Building&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,472&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;711,805&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Intangible lease assets &amp;#x2014; subject to amortization (weighted
 average useful life of 19.4&amp;#xA0;years in 2016 and 28.4&amp;#xA0;years
 in 2015)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;10,754&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;144,900&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;365,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net investments in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;63,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;170,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;514,484&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total assets acquired&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;213,100&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,020,198&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans repaid (1)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(93,262&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(385,851&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total net assets acquired&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;119,838&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,634,347&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="13%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;$93.3 million loans advanced to
 Capella in 2015 and repaid in 2016 as a part of the Capella
 transaction. $385.9 million loans advanced to MEDIAN in 2014 and
 repaid in 2015 as a part of the MEDIAN transaction.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B47A03BE-2EA2-4963-A3F3-0E37337F3384_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 At September 30, 2016, these amounts were as follows (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="63%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 37.55pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Asset Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;br /&gt;
 Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,550&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,550&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Mortgage&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Acquisition and other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;116,585&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;116,585&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Other loans&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Other assets&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;222,435&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;222,435&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_7D3E4551-8EE9-4720-85DE-D172B159E33C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 The carrying value and classification of the related assets and
 maximum exposure to loss as a result of our involvement with these
 VIEs are presented below at September&amp;#xA0;30, 2016 (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="48%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 33.6pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;VIE Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Maximum&amp;#xA0;Loss&lt;br /&gt;
 Exposure(1)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;br /&gt;
 Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 &amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Amount(2)&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;306,928&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;
 Mortgage&amp;#xA0;and&amp;#xA0;other&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;226,117&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;32,325&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other assets&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;207&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Our maximum loss exposure related to
 loans with VIEs represents our current aggregate gross carrying
 value of the loan plus accrued interest and any other related
 assets (such as rent receivables), less any liabilities. Our
 maximum loss exposure related to our equity investment in VIEs
 represents the current carrying values of such investment plus any
 other related assets (such as rent receivables) less any
 liabilities.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(2)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Carrying amount reflects the net book
 value of our loan or equity interest only in the VIE.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_511A7E9A-6DCF-4191-ACC0-E999076DE635_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;2. Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Unaudited Interim Condensed Consolidated Financial
 Statements&lt;/i&gt;: The accompanying unaudited interim condensed
 consolidated financial statements have been prepared in accordance
 with accounting principles generally accepted in the U.S. for
 interim financial information, including rules and regulations of
 the Securities and Exchange Commission. Accordingly, they do not
 include all of the information and footnotes required by generally
 accepted accounting principles (&amp;#x201C;GAAP&amp;#x201D;) for complete
 financial statements. In the opinion of management, all adjustments
 (consisting of normal recurring accruals) considered necessary for
 a fair presentation have been included. Operating results for the
 three and nine month periods ended September&amp;#xA0;30, 2016, are not
 necessarily indicative of the results that may be expected for the
 year ending December&amp;#xA0;31, 2016. The condensed consolidated
 balance sheet at December&amp;#xA0;31, 2015 has been derived from the
 audited financial statements at that date but does not include all
 of the information and footnotes required by accounting principles
 generally accepted in the U.S. for complete financial
 statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 For information about significant accounting policies, refer to the
 consolidated financial statements and footnotes thereto included in
 our Annual Report on Form 10-K for the year ended December&amp;#xA0;31,
 2015. During the nine months ended September&amp;#xA0;30, 2016, there
 were no material changes to these policies.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Recent Accounting Developments:&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 43px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In May 2014, the Financial Accounting Standards Board
 (&amp;#x201C;FASB&amp;#x201D;) issued Accounting Standards Update
 (&amp;#x201C;ASU&amp;#x201D;) No. 2014-09,&amp;#xA0;&lt;i&gt;Revenue from Contracts with
 Customers&lt;/i&gt;. Under the new standard, revenue is recognized at the
 time a good or service is transferred to a customer for the amount
 of consideration received for that specific good or service.
 Entities may use a full retrospective approach or report the
 cumulative effect as of the date of adoption. On April 1, 2015, the
 FASB proposed deferring the effective date of this standard by one
 year to December 15, 2017, for annual reporting periods beginning
 after that date. The FASB also proposed permitting early adoption
 of the standard, but not before the original effective date of
 December 15, 2016. We are continuing to evaluate this standard;
 however, we do not expect it to have a significant impact on our
 financial results, as a substantial portion of our revenue consists
 of rental income from leasing arrangements, which are specifically
 excluded from ASU No. 2014-09.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 43px; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Leases&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In February 2016, the FASB issued
 ASU&amp;#xA0;2016-02&amp;#xA0;-&amp;#xA0;&lt;i&gt;Leases&lt;/i&gt;, which sets out the
 principles for the recognition, measurement, presentation and
 disclosure of leases for both parties to a contract (i.e. lessees
 and lessors).&amp;#xA0;The new standard requires lessees to apply a
 dual approach, classifying leases as either financing or operating
 leases based on the principle of whether or not the lease is
 effectively a financed purchase by the lessee.&amp;#xA0;This
 classification will determine&amp;#xA0;whether lease expense is
 recognized&amp;#xA0;based on an effective interest
 method&amp;#xA0;or&amp;#xA0;on a straight line basis over the term of the
 lease.&amp;#xA0;A lessee is also required to record a right-of-use
 asset and a lease liability for all leases with a term of greater
 than 12 months regardless of their classification.&amp;#xA0;Leases with
 a term of 12 months or less will be accounted for similar to
 existing guidance for operating leases today. The new standard
 requires lessors to account for leases using an approach that is
 substantially equivalent to existing guidance for sales-type
 leases, direct financing leases and operating leases. The ASU is
 not effective for us until January&amp;#xA0;1, 2019 with early adoption
 permitted. We are continuing to evaluate this standard and the
 impact to us from both a lessor and a lessee perspective.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 43px; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Measurement of Credit Losses on Financial Instruments&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In June 2016, the FASB issued ASU 2016-13,&amp;#xA0;&lt;i&gt;Measurement of Credit
 Losses on Financial Instruments&lt;/i&gt;, which is intended to improve
 financial reporting by requiring timely recording of credit losses
 on loans and other financial instruments held by financial
 institutions and other organizations.&amp;#xA0;The ASU requires the
 measurement of all expected credit losses for financial assets not
 recorded at fair value based on historical experience, current
 conditions, and reasonable and supportable forecasts.&amp;#xA0;The ASU
 will be required to be implemented through a cumulative-effect
 adjustment to retained earnings as of the beginning of the first
 reporting period in which the amendments are effective.&amp;#xA0;The
 ASU is not effective for us until January 1, 2019. We do not expect
 the adoption of this ASU to have a significant impact on our
 consolidated financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 43px; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Classification of Certain Cash Receipts and Cash
 Payments&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In August 2016, the FASB issued ASU No. 2016-15,&amp;#xA0;&lt;i&gt;Classification of Certain
 Cash Receipts and Cash Payments&lt;/i&gt;, which clarifies the
 classification within the statement of cash flows for certain
 transactions, including debt extinguishment costs, zero-coupon
 debt, contingent consideration related to business combinations,
 insurance proceeds, equity method distributions and beneficial
 interests in securitizations. The standard also clarifies that cash
 flows with aspects of multiple classes of cash flows or that cannot
 be separated by source or use should be classified based on the
 activity that is likely to be the predominant source or use of cash
 flows for the item. This guidance is effective for us starting
 January 1, 2018.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Variable Interest Entities&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 At September&amp;#xA0;30, 2016, we had loans to and/or equity
 investments in certain variable interest entities
 (&amp;#x201C;VIEs&amp;#x201D;), which are also tenants of our facilities,
 including Ernest Health, Inc. (&amp;#x201C;Ernest&amp;#x201D;). We have
 determined that we are not the primary beneficiary of these VIEs.
 The carrying value and classification of the related assets and
 maximum exposure to loss as a result of our involvement with these
 VIEs are presented below at September&amp;#xA0;30, 2016 (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="48%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 33.6pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;VIE Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Maximum&amp;#xA0;Loss&lt;br /&gt;
 Exposure(1)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;br /&gt;
 Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 &amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Amount(2)&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;306,928&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;
 Mortgage&amp;#xA0;and&amp;#xA0;other&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;226,117&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;32,325&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other assets&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;207&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Our maximum loss exposure related to
 loans with VIEs represents our current aggregate gross carrying
 value of the loan plus accrued interest and any other related
 assets (such as rent receivables), less any liabilities. Our
 maximum loss exposure related to our equity investment in VIEs
 represents the current carrying values of such investment plus any
 other related assets (such as rent receivables) less any
 liabilities.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(2)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Carrying amount reflects the net book
 value of our loan or equity interest only in the VIE.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 For the VIE types above, we do not consolidate the VIE because we
 do not have the ability to control the activities (such as the
 day-to-day healthcare operations of our borrower or investees) that
 most significantly impact the VIE&amp;#x2019;s economic performance. As
 of September&amp;#xA0;30, 2016, we were not required to provide any
 material financial support through a liquidity arrangement or
 otherwise to our unconsolidated VIEs, including circumstances in
 which it could be exposed to further losses (e.g., cash short
 falls).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 Typically, our loans are collateralized by assets of the borrower
 (some assets of which are on the premises of facilities owned by
 us) and further supported by limited guarantees made by certain
 principals of the borrower.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 See Note 3 and 7 for additional description of the nature, purpose
 and activities of our more significant VIEs and interests
 therein.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <dei:TradingSymbol contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1_0">MPW</dei:TradingSymbol>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_8" unitRef="shares">241432000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_6" unitRef="shares">240607000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <dei:AmendmentFlag contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1_1">false</dei:AmendmentFlag>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_AC170DEE-AB6D-4859-ACEB-EE47887A764C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Unaudited Interim Condensed Consolidated Financial
 Statements&lt;/i&gt;: The accompanying unaudited interim condensed
 consolidated financial statements have been prepared in accordance
 with accounting principles generally accepted in the U.S. for
 interim financial information, including rules and regulations of
 the Securities and Exchange Commission. Accordingly, they do not
 include all of the information and footnotes required by generally
 accepted accounting principles (&amp;#x201C;GAAP&amp;#x201D;) for complete
 financial statements. In the opinion of management, all adjustments
 (consisting of normal recurring accruals) considered necessary for
 a fair presentation have been included. Operating results for the
 three and nine month periods ended September&amp;#xA0;30, 2016, are not
 necessarily indicative of the results that may be expected for the
 year ending December&amp;#xA0;31, 2016. The condensed consolidated
 balance sheet at December&amp;#xA0;31, 2015 has been derived from the
 audited financial statements at that date but does not include all
 of the information and footnotes required by accounting principles
 generally accepted in the U.S. for complete financial
 statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 For information about significant accounting policies, refer to the
 consolidated financial statements and footnotes thereto included in
 our Annual Report on Form 10-K for the year ended December&amp;#xA0;31,
 2015. During the nine months ended September&amp;#xA0;30, 2016, there
 were no material changes to these policies.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_28" unitRef="iso4217_USD_per_shares">0.75</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_C9329A93-3E31-42C4-ADE0-9B14E9870722_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 21px; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;&lt;i&gt;Gross Assets by U.S. State and Country&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of September&amp;#xA0;30,
 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of December&amp;#xA0;31, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;U.S. States and Other
 Countries&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Massachusetts&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Texas&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;944,028&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,060,990&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 California&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;542,892&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;547,085&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 All other states&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,669,401&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;37.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,047,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;50.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other domestic assets&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;251,587&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;177,317&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.9&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total U.S.&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,657,908&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;78.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,832,596&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Germany&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,376,626&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,031,039&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 United Kingdom, Italy, and Spain&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;156,226&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;161,317&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.7&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other international assets&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;27,017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;10,970&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total International&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,559,869&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;21.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,203,326&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.9&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Grand Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,217,777&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,035,922&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 2pt; WIDTH: 53px; WHITE-SPACE: normal; WORD-SPACING: 0px; BORDER-BOTTOM: rgb(0,0,0) 1px solid; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: medium/8pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Gross Assets represents total assets
 plus accumulated depreciation/amortization assuming all real estate
 commitments (such as the Steward transaction and the commitments
 disclosed in Note 9) as of the period end are fully funded.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(B)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Includes both leased and loaned
 assets.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_50145AE9-B6B8-4A60-A4BC-3B63432E4F7E_1_0">&lt;div&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;1. Organization&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 Medical Properties Trust, Inc., a Maryland corporation, was formed
 on August&amp;#xA0;27, 2003, under the Maryland General Corporation Law
 for the purpose of engaging in the business of investing in,
 owning, and leasing commercial real estate. Our operating
 partnership subsidiary, MPT Operating Partnership, L.P., (the
 &amp;#x201C;Operating Partnership&amp;#x201D;) through which we conduct all
 of our operations, was formed in September 2003. Through another
 wholly-owned subsidiary, Medical Properties Trust, LLC, we are the
 sole general partner of the Operating Partnership. At present, we
 directly own substantially all of the limited partnership interests
 in the Operating Partnership and have elected to report our
 required disclosures and that of the Operating Partnership on a
 combined basis except where material differences exist.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 We have operated as a real estate investment trust
 (&amp;#x201C;REIT&amp;#x201D;) since April&amp;#xA0;6, 2004, and accordingly,
 elected REIT status upon the filing in September 2005 of the
 calendar year 2004 federal income tax return. Accordingly, we will
 generally not be subject to federal income tax in the United States
 (&amp;#x201C;U.S.&amp;#x201D;), provided that we continue to qualify as a
 REIT and our distributions to our stockholders equal or exceed our
 taxable income. Certain activities we undertake must be conducted
 by entities which we elected to be treated as taxable REIT
 subsidiaries (&amp;#x201C;TRSs&amp;#x201D;). Our TRSs are subject to both
 U.S. federal and state income taxes. For our properties located
 outside the U.S., we are subject to local taxes; however, we do not
 expect to incur additional taxes in the U.S. as such income will
 flow through our REIT.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 Our primary business strategy is to acquire and develop real estate
 and improvements, primarily for long-term lease to providers of
 healthcare services such as operators of general acute care
 hospitals, inpatient physical rehabilitation hospitals, long-term
 acute care hospitals, surgery centers, centers for treatment of
 specific conditions such as cardiac, pulmonary, cancer, and
 neurological hospitals, and other healthcare-oriented facilities.
 We also make mortgage and other loans to operators of similar
 facilities. In addition, we may obtain profits or equity interests
 in our tenants, from time to time, in order to enhance our overall
 return. We manage our business as a single business segment. All of
 our properties are located in the U.S. and Europe.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_8E4873A7-F613-49F0-9FBE-CAB15ABC9B63_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Revenue by U.S. State and Country&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="58%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 109.7pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;U.S. States and Other Countries&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Texas&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;72,811&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;63,815&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;20.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 California&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;49,724&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;49,595&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;16.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 All other states&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;189,365&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;48.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;137,006&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;44.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total U.S.&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;311,900&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;250,416&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80.7&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Germany&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;72,718&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;56,609&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 United Kingdom, Italy, and Spain&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,236&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,308&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total International&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;75,954&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,917&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Grand Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;387,854&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;310,333&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
  <us-gaap:ScheduleOfDebtTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_5B130AEA-8600-48C0-BA05-99C06C74798C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 The following is a summary of our debt (dollar amounts in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;September 30,
 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Revolving credit facility&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2006 Senior Unsecured Notes due 2016&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;60,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.675&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2011 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;450,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.875&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2012 Senior Unsecured Notes due 2022:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Principal amount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Unamortized premium&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,902&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,168&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;351,902&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;352,168&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2013 Senior Unsecured Notes due 2020(A)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;224,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;217,240&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2014 Senior Unsecured Notes due 2024&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2015 Senior Unsecured Notes due 2022(A)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;561,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;543,100&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2016 Senior Unsecured Notes due 2024&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;500,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2016 Senior Unsecured Notes due 2026&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;500,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.250&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Term loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;263,179&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;263,400&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,761,531&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,350,908&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Debt issue costs, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(32,982&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(28,367&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,728,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,322,541&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;These notes are Euro-denominated and
 reflect the exchange rate at September&amp;#xA0;30, 2016 and
 December&amp;#xA0;31, 2015, respectively.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_D1432C11-F416-4285-BECA-868814EB60F5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Medical Properties Trust, Inc.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 Our earnings per share were calculated based on the following (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="78%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,543&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,123&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(185&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(154&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(265&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from discontinued operations attributable to MPT common
 stockholders&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;246,230&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,238&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average common&amp;#xA0;&lt;br /&gt;
 shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;247,468&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;182,693&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;81,589&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(683&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(430&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(781&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loss from discontinued operations attributable to MPT common
 stockholders&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,579&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;240,607&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211,659&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;825&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;409&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average common&amp;#xA0;&lt;br /&gt;
 shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;241,432&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;212,068&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;MPT Operating Partnership, L.P.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 Our earnings per common unit were calculated based on the following
 (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="78%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,543&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,123&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(185&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(154&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(265&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from discontinued operations attributable to MPT Operating
 Partnership partners&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;246,230&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,238&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;247,468&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;182,693&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;81,589&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(683&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(430&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(781&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loss from discontinued operations attributable to MPT Operating
 Partnership partners&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,579&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;240,607&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211,659&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;825&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;409&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;241,432&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;212,068&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_3_2" unitRef="iso4217_USD_per_shares">0.64</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="INF" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_37" unitRef="iso4217_USD_per_shares">0.68</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_58C1D649-13E5-47B8-826B-1F820D4C4B45_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 As of September&amp;#xA0;30, 2016, principal payments due on our debt
 (which exclude the effects of any discounts, premiums, or debt
 issue costs recorded) are as follows (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2016&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;60,078&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;(A)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2017&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;320&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2018&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12,781&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2019&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2020&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;224,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Thereafter&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,211,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,759,629&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 2pt; WIDTH: 10%; BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0pt; LINE-HEIGHT: 8pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;The remaining $60 million of our 2006
 Senior Unsecured Notes were paid in full on October 31, 2016.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1_3">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentPeriodEndDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1_2">2016-09-30</dei:DocumentPeriodEndDate>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_30" unitRef="iso4217_USD_per_shares">0.75</us-gaap:EarningsPerShareBasic>
  <dei:EntityFilerCategory contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1_4">Large Accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_7" unitRef="shares">825000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_16" unitRef="iso4217_USD">168289000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_7D222437-53BD-47CC-800E-5656F8F85F29_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The following unaudited supplemental pro forma operating data is
 presented for the three and nine months ended September&amp;#xA0;30,
 2016 and 2015, as if each acquisition (including the Steward
 investments completed subsequent to September&amp;#xA0;30, 2016) was
 completed on January&amp;#xA0;1, 2015. Supplemental pro forma earnings
 were adjusted to exclude acquisition-related costs on consummated
 deals incurred. The unaudited supplemental pro forma operating data
 is not necessarily indicative of what the actual results of
 operations would have been assuming the transactions had been
 completed as set forth above, nor do they purport to represent our
 results of operations for future periods (in thousands, except per
 share/unit amounts).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="72%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total revenues&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;162.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;156.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;479.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;480.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;73.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;63.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;206.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;227.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income per share/unit &amp;#x2014; diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.23&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.20&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.64&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.71&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
  <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_01B47A97-9137-43B4-85DC-3814CF75D7F6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Variable Interest Entities&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 At September&amp;#xA0;30, 2016, we had loans to and/or equity
 investments in certain variable interest entities
 (&amp;#x201C;VIEs&amp;#x201D;), which are also tenants of our facilities,
 including Ernest Health, Inc. (&amp;#x201C;Ernest&amp;#x201D;). We have
 determined that we are not the primary beneficiary of these VIEs.
 The carrying value and classification of the related assets and
 maximum exposure to loss as a result of our involvement with these
 VIEs are presented below at September&amp;#xA0;30, 2016 (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="48%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 33.6pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;VIE Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Maximum&amp;#xA0;Loss&lt;br /&gt;
 Exposure(1)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;br /&gt;
 Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 &amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;Amount(2)&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;306,928&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;
 Mortgage&amp;#xA0;and&amp;#xA0;other&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;226,117&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;32,325&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other assets&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;207&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Our maximum loss exposure related to
 loans with VIEs represents our current aggregate gross carrying
 value of the loan plus accrued interest and any other related
 assets (such as rent receivables), less any liabilities. Our
 maximum loss exposure related to our equity investment in VIEs
 represents the current carrying values of such investment plus any
 other related assets (such as rent receivables) less any
 liabilities.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(2)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Carrying amount reflects the net book
 value of our loan or equity interest only in the VIE.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 For the VIE types above, we do not consolidate the VIE because we
 do not have the ability to control the activities (such as the
 day-to-day healthcare operations of our borrower or investees) that
 most significantly impact the VIE&amp;#x2019;s economic performance. As
 of September&amp;#xA0;30, 2016, we were not required to provide any
 material financial support through a liquidity arrangement or
 otherwise to our unconsolidated VIEs, including circumstances in
 which it could be exposed to further losses (e.g., cash short
 falls).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 Typically, our loans are collateralized by assets of the borrower
 (some assets of which are on the premises of facilities owned by
 us) and further supported by limited guarantees made by certain
 principals of the borrower.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 See Note 3 and 7 for additional description of the nature, purpose
 and activities of our more significant VIEs and interests
 therein.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_70DD94AB-036F-42BB-88B8-3D0F08CD71EC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;8. Earnings Per Share/Common Unit&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Medical Properties Trust, Inc.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 Our earnings per share were calculated based on the following (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="78%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,543&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,123&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(185&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(154&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(265&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from discontinued operations attributable to MPT common
 stockholders&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;246,230&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,238&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average common&amp;#xA0;&lt;br /&gt;
 shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;247,468&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;182,693&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;81,589&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(683&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(430&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(781&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loss from discontinued operations attributable to MPT common
 stockholders&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,579&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;240,607&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211,659&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;825&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;409&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average common&amp;#xA0;&lt;br /&gt;
 shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;241,432&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;212,068&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;MPT Operating Partnership, L.P.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 Our earnings per common unit were calculated based on the following
 (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="78%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,543&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,123&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(185&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(154&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(265&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from discontinued operations attributable to MPT Operating
 Partnership partners&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;22,792&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;246,230&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,238&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;247,468&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;223,948&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine Months&lt;br /&gt;
 Ended&amp;#xA0;September 30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;182,693&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;81,589&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(683&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(430&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(781&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loss from discontinued operations attributable to MPT Operating
 Partnership partners&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;181,579&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80,580&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;240,607&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211,659&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive potential units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;825&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;409&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;241,432&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;212,068&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <dei:EntityRegistrantName contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1_1">MEDICAL PROPERTIES TRUST INC</dei:EntityRegistrantName>
  <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_C7DD6377-0845-4DEA-8FCB-80BEE320EF30_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 The following table summarizes fair value estimates for our
 financial instruments (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;September&amp;#xA0;30,&amp;#xA0;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;December&amp;#xA0;31, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 54.75pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Asset (Liability)&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Interest and rent receivables&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;54,554&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;54,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;46,939&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;46,858&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans (1)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;496,767&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;529,053&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;508,851&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;543,859&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Debt, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,728,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,875,619&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(3,322,541&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(3,372,773&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Excludes loans related to Ernest and
 Capella (2015 only) since they are recorded at fair value and
 discussed below.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_14705C0D-73B7-448D-8B93-583C822180FB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;7. Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We have various assets and liabilities that are considered
 financial instruments. We estimate that the carrying value of cash
 and cash equivalents, and accounts payable and accrued expenses
 approximate their fair values. Included in our accounts payable and
 accrued expenses are our interest rate swaps, which are recorded at
 fair value based on Level 2 observable market assumptions using
 standardized derivative pricing models. We estimate the fair value
 of our interest and rent receivables using Level 2 inputs such as
 discounting the estimated future cash flows using the current rates
 at which similar receivables would be made to others with similar
 credit ratings and for the same remaining maturities. The fair
 value of our mortgage loans and working capital loans are estimated
 by using Level 2 inputs such as discounting the estimated future
 cash flows using the current rates which similar loans would be
 made to borrowers with similar credit ratings and for the same
 remaining maturities. We determine the fair value of our senior
 unsecured notes (excluding our 2006 Senior Unsecured Notes) using
 Level 2 inputs such as quotes from securities dealers and market
 makers. We estimate the fair value of our 2006 Senior Unsecured
 Notes, our revolving credit facility, and term loans using Level 2
 inputs based on the present value of future payments, discounted at
 a rate which we consider appropriate for such debt.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 Fair value estimates are made at a specific point in time, are
 subjective in nature, and involve uncertainties and matters of
 significant judgment. Settlement of such fair value amounts may not
 be possible and may not be a prudent management decision. The
 following table summarizes fair value estimates for our financial
 instruments (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;September&amp;#xA0;30,&amp;#xA0;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;December&amp;#xA0;31, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 54.75pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Asset (Liability)&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Interest and rent receivables&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;54,554&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;54,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;46,939&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;46,858&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans (1)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;496,767&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;529,053&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;508,851&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;543,859&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Debt, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,728,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,875,619&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(3,322,541&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(3,372,773&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Excludes loans related to Ernest and
 Capella (2015 only) since they are recorded at fair value and
 discussed below.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Items Measured at Fair Value on a Recurring Basis&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"&gt;
 Our equity interest in Ernest and related loans, which were
 acquired in 2012, are being measured at fair value on a recurring
 basis as we elected to account for these investments using the fair
 value option method. We have elected to account for these
 investments at fair value due to the size of the investments and
 because we believe this method is more reflective of current
 values. We have not made a similar election for other equity
 interests or loans made in or prior to 2016, except for our
 investments in Capella that were disposed of in the 2016 second
 quarter.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 At September 30, 2016, these amounts were as follows (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="63%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 37.55pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Asset Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;br /&gt;
 Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,550&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,550&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Mortgage&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Acquisition and other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;116,585&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;116,585&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Other loans&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Other assets&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;222,435&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;222,435&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 Our mortgage loans with Ernest are recorded at fair value based on
 Level 2 inputs by discounting the estimated cash flows using the
 market rates which similar loans would be made to borrowers with
 similar credit ratings and the same remaining maturities. Our
 acquisition loans and equity investments in Ernest are recorded at
 fair value based on Level 3 inputs, by using a discounted cash flow
 model, which requires significant estimates of our investee such as
 projected revenue and expenses and appropriate consideration of the
 underlying risk profile of the forecast assumptions associated with
 the investee. We classify these loans and equity investments as
 Level 3, as we use certain unobservable inputs to the valuation
 methodology that are significant to the fair value measurement, and
 the valuation requires management judgment due to the absence of
 quoted market prices. For these cash flow models, our observable
 inputs include use of a capitalization rate, discount rate (which
 is based on a weighted-average cost of capital), and market
 interest rates, and our unobservable input includes an adjustment
 for a marketability discount (&amp;#x201C;DLOM&amp;#x201D;) on our equity
 investment of 40% at September 30, 2016.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In regards to the underlying projection of revenues and expenses
 used in the discounted cash flow model, such projections are
 provided by Ernest. However, we will modify such projections
 (including underlying assumptions used) as needed based on our
 review and analysis of Ernest&amp;#x2019;s historical results, meetings
 with key members of management, and our understanding of trends and
 developments within the healthcare industry.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In arriving at the DLOM, we started with a DLOM range based on the
 results of studies supporting valuation discounts for other
 transactions or structures without a public market. To select the
 appropriate DLOM within the range, we then considered many
 qualitative factors including the percent of control, the nature of
 the underlying investee&amp;#x2019;s business along with our rights as
 an investor pursuant to the operating agreement, the size of
 investment, expected holding period, number of shareholders, access
 to capital marketplace, etc. To illustrate the effect of movements
 in the DLOM, we performed a sensitivity analysis below by using
 basis point variations (dollars in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="28%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 156.5pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Basis&amp;#xA0;Point Change&amp;#xA0;in
 Marketability&amp;#xA0;Discount&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;Estimated&amp;#xA0;Increase&amp;#xA0;(Decrease)&lt;br /&gt;
 In Fair Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 +100&amp;#xA0;basis&amp;#xA0;points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(61&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 - 100&amp;#xA0;basis&amp;#xA0;points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;61&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 Because the fair value of Ernest investments noted above
 approximate their original cost, we did not recognize any
 unrealized gains/losses during the first nine months of 2016 or
 2015.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:LongTermDebtTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_E3059325-3769-4A19-9473-847BEAE9928F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;4. Debt&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 The following is a summary of our debt (dollar amounts in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;September 30,
 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Revolving credit facility&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2006 Senior Unsecured Notes due 2016&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;60,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.675&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2011 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;450,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.875&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2012 Senior Unsecured Notes due 2022:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Principal amount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Unamortized premium&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,902&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,168&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;351,902&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;352,168&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2013 Senior Unsecured Notes due 2020(A)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;224,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;217,240&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2014 Senior Unsecured Notes due 2024&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2015 Senior Unsecured Notes due 2022(A)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;561,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;543,100&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2016 Senior Unsecured Notes due 2024&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;500,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2016 Senior Unsecured Notes due 2026&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;500,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.250&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Term loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;263,179&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;263,400&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,761,531&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,350,908&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Debt issue costs, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(32,982&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(28,367&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,728,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,322,541&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;These notes are Euro-denominated and
 reflect the exchange rate at September&amp;#xA0;30, 2016 and
 December&amp;#xA0;31, 2015, respectively.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 As of September&amp;#xA0;30, 2016, principal payments due on our debt
 (which exclude the effects of any discounts, premiums, or debt
 issue costs recorded) are as follows (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2016&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;60,078&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;(A)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2017&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;320&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2018&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12,781&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2019&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 2020&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;224,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Thereafter&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,211,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,759,629&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 2pt; WIDTH: 156px; WHITE-SPACE: normal; WORD-SPACING: 0px; BORDER-BOTTOM: rgb(0,0,0) 1px solid; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: medium/8pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;The remaining $60 million of our 2006
 Senior Unsecured Notes were paid in full on October 31, 2016.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;u&gt;2016 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On July 22, 2016, we completed a $500 million senior unsecured
 notes offering (&amp;#x201C;2026 Senior Unsecured Notes&amp;#x201D;).
 Interest on the notes is payable on February&amp;#xA0;1 and
 August&amp;#xA0;1 of each year, commencing on February 1, 2017.
 Interest on the notes is to be paid in cash at a rate of 5.25% per
 year. The notes mature on August 1, 2026. We may redeem some or all
 of the notes at any time prior to August&amp;#xA0;1, 2021 at a
 &amp;#x201C;make whole&amp;#x201D; redemption price. On or after August 1,
 2021, we may redeem some or all of the notes at a premium that will
 decrease over time. In addition, at any time prior to August 1,
 2019, we may redeem up to 35% of the notes at a redemption price
 equal to 105.25% of the aggregate principal amount thereof, plus
 accrued and unpaid interest thereon, using proceeds from one or
 more equity offerings. In the event of a change in control, each
 holder of the notes may require us to repurchase some or all of the
 notes at a repurchase price equal to 101% of the aggregate
 principal amount of the notes plus accrued and unpaid interest to
 the date of purchase.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We used the net proceeds from the 2026 Senior Unsecured Notes
 offering to redeem our $450 million 2011 Senior Unsecured
 Notes.&amp;#xA0;This redemption resulted in a $22.5 million debt
 refinancing charge during the 2016 third quarter, consisting of a
 $15.5 million redemption premium along with the write-off of
 deferred debt issuance costs associated with the redeemed
 notes.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On February&amp;#xA0;22, 2016, we completed a $500 million senior
 unsecured notes offering (&amp;#x201C;2016 Senior Unsecured
 Notes&amp;#x201D;), proceeds of which were used to repay borrowings
 under our revolving credit facility. Interest on the notes is
 payable on March&amp;#xA0;1 and September&amp;#xA0;1 of each year,
 commencing on September&amp;#xA0;1, 2016. Interest on the notes is to
 be paid in cash at a rate of 6.375%&amp;#xA0;per year. The notes mature
 on March&amp;#xA0;1, 2024. We may redeem some or all of the notes at
 any time prior to March&amp;#xA0;1, 2019 at a &amp;#x201C;make whole&amp;#x201D;
 redemption price. On or after March&amp;#xA0;1, 2019, we may redeem
 some or all of the notes at a premium that will decrease over time.
 In addition, at any time prior to March&amp;#xA0;1, 2019, we may redeem
 up to 35% of the notes at a redemption price equal to 106.375% of
 the aggregate principal amount thereof, plus accrued and unpaid
 interest thereon, using proceeds from one or more equity offerings.
 In the event of a change in control, each holder of the notes may
 require us to repurchase some or all of the notes at a repurchase
 price equal to 101% of the aggregate principal amount of the notes
 plus accrued and unpaid interest to the date of purchase.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;u&gt;2015 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On July 27, 2015, we received a commitment to provide a senior
 unsecured bridge loan facility in the original principal amount of
 $1.0 billion to fund the acquisition of Capella.&amp;#xA0;Funding under
 the bridge facility was not necessary as we funded the acquisition
 through a combination of an equity issuance and other borrowings.
 However, we incurred and expensed certain customary structuring and
 underwriting fees of $3.9 million in the third quarter related to
 the bridge commitment.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On August 19, 2015, we completed a &amp;#x20AC;500 million senior
 unsecured notes offering (&amp;#x201C;2015 Senior Unsecured
 Notes&amp;#x201D;), proceeds of which were used to repay
 Euro-denominated borrowings under our credit facility and to fund
 our European investments.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 On September 30, 2015, we amended our credit facility to, among
 other things, increase the aggregate commitment under&amp;#xA0;our
 revolver to its current level of $1.3 billion and increase the term
 loan portion to $250 million. In addition, this amendment included
 a new accordion feature that allows us to expand our credit
 facility by another $400 million for a total commitment of $1.95
 billion. This amendment resulted in a $0.1 million expense in the
 2015 third quarter.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;u&gt;Other&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 During the 2010 second quarter, we entered into interest rate swaps
 to manage our exposure to variable interest rates by fixing the
 interest rate on the outstanding amount of our 2006 Senior
 Unsecured Notes.&amp;#xA0;In July 2016, $65 million of the 2006 Senior
 Unsecured Notes was paid in full and the related swap
 expired.&amp;#xA0;For the remaining $60 million, the interest rate
 swap, which started October&amp;#xA0;31, 2011 (date on which the
 related interest rate turned variable) and will continue through
 the maturity date (or October 2016) fixed the interest rate at
 5.675%. The fair value of the interest rate swaps was $0.4 million
 and $2.9 million as of September&amp;#xA0;30, 2016 and
 December&amp;#xA0;31, 2015, respectively, which is reflected in
 accounts payable and accrued expenses on the consolidated balance
 sheets.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We account for interest rate swaps as cash flow hedges.
 Accordingly, the effective portion of changes in the fair value of
 our swaps is recorded as a component of accumulated other
 comprehensive income/loss on the balance sheet and reclassified
 into earnings in the same period, or periods, during which the
 hedged transactions effect earnings, while any ineffective portion
 is recorded through earnings immediately. We did not have any hedge
 ineffectiveness from inception of our interest rate swaps through
 September&amp;#xA0;30, 2016 and therefore, there was no income
 statement effect recorded during the three and nine month periods
 ended September&amp;#xA0;30, 2016 or 2015. We do expect current losses
 included in accumulated other comprehensive loss to be reclassified
 into earnings in October 2016. At September&amp;#xA0;30, 2016 and
 December&amp;#xA0;31, 2015, we have posted $0.4 million and $1.7
 million, respectively, of collateral related to our interest rate
 swaps, which is reflected in other assets on our consolidated
 balance sheets.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Covenants&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 Our debt facilities impose certain restrictions on us, including
 restrictions on our ability to: incur debts; create or incur liens;
 provide guarantees in respect of obligations of any other entity;
 make redemptions and repurchases of our capital stock; prepay,
 redeem or repurchase debt; engage in mergers or consolidations;
 enter into affiliated transactions; dispose of real estate or other
 assets; and change our business. In addition, the credit agreements
 governing our revolving credit facility and term loan limit the
 amount of dividends we can pay as a percentage of normalized
 adjusted funds from operations (&amp;#x201C;FFO&amp;#x201D;), as defined in
 the agreements, on a rolling four quarter basis. At
 September&amp;#xA0;30, 2016, the dividend restriction was 95% of
 normalized adjusted FFO. The indentures governing our senior
 unsecured notes also limit the amount of dividends we can pay based
 on the sum of 95% of funds from operations, proceeds of equity
 issuances and certain other net cash proceeds. Finally, our senior
 unsecured notes require us to maintain total unencumbered assets
 (as defined in the related indenture) of not less than 150% of our
 unsecured indebtedness.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In addition to these restrictions, the revolving credit facility
 and term loan contain customary financial and operating covenants,
 including covenants relating to our total leverage ratio, fixed
 charge coverage ratio, secured leverage ratio, consolidated
 adjusted net worth, unsecured leverage ratio, and unsecured
 interest coverage ratio. This facility also contains customary
 events of default, including among others, nonpayment of principal
 or interest, material inaccuracy of representations and failure to
 comply with our covenants. If an event of default occurs and is
 continuing under the facility, the entire outstanding balance may
 become immediately due and payable. At September&amp;#xA0;30, 2016, we
 were in compliance with all such financial and operating
 covenants.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_F67BF846-2FB8-499B-9FC1-60529D099CD9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 The properties sold during the year do not meet the definition of
 discontinued operations. However, the following represents the
 operating results (excluding gain on sale, transaction costs, and
 impairment or other non-cash charges) from these properties
 (excluding loans repaid in the Capella Disposal Transaction) for
 the periods presented (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="68%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Revenues&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;244&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,523&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,851&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13,598&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Real estate depreciation and amortization&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(949&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,754&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,846&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Property-related expenses&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(10&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(114&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(82&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other income (expense)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(24&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;521&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(92&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,078&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from real estate dispositions, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;220&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,085&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,891&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,748&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;br class="Apple-interchange-newline" /&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_5" unitRef="iso4217_USD">387854000</us-gaap:Revenues>
  <us-gaap:PaymentsForProceedsFromLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_21" unitRef="iso4217_USD">102909000</us-gaap:PaymentsForProceedsFromLoansReceivable>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_3_3" unitRef="iso4217_USD">10354000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_4" unitRef="iso4217_USD">79756000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_3_0" unitRef="iso4217_USD">7851000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_3_4" unitRef="iso4217_USD">5891000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_42" unitRef="iso4217_USD">17458000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_4" unitRef="iso4217_USD">27009000</us-gaap:StraightLineRent>
  <us-gaap:PaymentsToAcquireNotesReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_23" unitRef="iso4217_USD">50000000</us-gaap:PaymentsToAcquireNotesReceivable>
  <us-gaap:PaymentsToAcquireOtherInvestments contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_25" unitRef="iso4217_USD">52701000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_31" unitRef="iso4217_USD">160060000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_13" unitRef="iso4217_USD">268917000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_26" unitRef="iso4217_USD">182009000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_40" unitRef="iso4217_USD">120374000</us-gaap:InterestPaid>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_23" unitRef="iso4217_USD">-1000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_16" unitRef="iso4217_USD">61294000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_3_4" unitRef="iso4217_USD">195540000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_3_6" unitRef="iso4217_USD">194857000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_3" unitRef="iso4217_USD">47181000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_30" unitRef="iso4217_USD">515221000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_24" unitRef="iso4217_USD">182692000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_4" unitRef="iso4217_USD">-1000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_0" unitRef="iso4217_USD">182693000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_9" unitRef="iso4217_USD">61294000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_3_1" unitRef="iso4217_USD">206300</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_18" unitRef="iso4217_USD">213100000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_19" unitRef="iso4217_USD">-118000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_12" unitRef="iso4217_USD">8398000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_3_2" unitRef="iso4217_USD">2494000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_21" unitRef="iso4217_USD">-86224000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_3_0" unitRef="iso4217_USD">479800</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_3" unitRef="iso4217_USD">69720000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_1" unitRef="iso4217_USD">683000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_20" unitRef="iso4217_USD">1173000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_15" unitRef="iso4217_USD">121132000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_32" unitRef="iso4217_USD">1024088000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_8" unitRef="iso4217_USD">5832000</us-gaap:ShareBasedCompensation>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_8" unitRef="iso4217_USD">7295000</us-gaap:AssetImpairmentCharges>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_10" unitRef="iso4217_USD">6379000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_7" unitRef="iso4217_USD">67850000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_9" unitRef="iso4217_USD">1592000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ImpairmentOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_5" unitRef="iso4217_USD">3063000</us-gaap:ImpairmentOfRealEstate>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_26" unitRef="iso4217_USD">495530000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_34" unitRef="iso4217_USD">-31317000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_10" unitRef="iso4217_USD">5799000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_12" unitRef="iso4217_USD">118937000</us-gaap:CostsAndExpenses>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_37" unitRef="iso4217_USD">4283000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_11" unitRef="iso4217_USD">35821000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_25" unitRef="iso4217_USD">683000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_20" unitRef="iso4217_USD">804809000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_28" unitRef="iso4217_USD">-1100000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_36" unitRef="iso4217_USD">895093000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_3_5" unitRef="iso4217_USD">683000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_6_2" unitRef="iso4217_USD">54154000</us-gaap:ContractRevenueCost>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_3_1" unitRef="iso4217_USD">1754000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_15" unitRef="iso4217_USD">-12403000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_35" unitRef="iso4217_USD">231274000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_29" unitRef="iso4217_USD">1000000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromSaleOfNotesReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_24" unitRef="iso4217_USD">50000000</us-gaap:ProceedsFromSaleOfNotesReceivable>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_19" unitRef="iso4217_USD">198767000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <mpw:PercentageOfEquitySharesFromConvertibleDebt contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="INF" id="id_8591822_9D351586-B445-4CE8-B6CE-50C02964D7E2_2_2" unitRef="pure">0.151</mpw:PercentageOfEquitySharesFromConvertibleDebt>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_3" unitRef="iso4217_USD">181580000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:ComponentsOfInvestmentInLeasesOfEquipmentTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_FCCBAB50-B564-42D1-BAE8-F7E99F24731B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The components of our net investment in DFLs (which includes the
 Capella properties for 2015 only) consisted of the following (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;As&amp;#xA0;of&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Minimum lease payments receivable&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,884,144&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,587,912&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Estimated residual values&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;292,647&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;393,097&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Less: Unearned income&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,643,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,354,013&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net investment in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;533,491&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;626,996&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:ComponentsOfInvestmentInLeasesOfEquipmentTableTextBlock>
  <mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_33" unitRef="iso4217_USD">-13784000</mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:MaximumPercentageOfUnencumberedAssets contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="INF" id="id_8591822_0446D40C-5E6C-4BF3-B2B7-93B585AE747E_1_2" unitRef="pure">1.50</mpw:MaximumPercentageOfUnencumberedAssets>
  <mpw:FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_E7D92E48-F5B8-46E8-92D4-69EAEA9971CA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 To illustrate the effect of movements in the DLOM, we performed a
 sensitivity analysis below by using basis point variations (dollars
 in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="28%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 156.5pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Basis&amp;#xA0;Point Change&amp;#xA0;in
 Marketability&amp;#xA0;Discount&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;Estimated&amp;#xA0;Increase&amp;#xA0;(Decrease)&lt;br /&gt;
 In Fair Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 +100&amp;#xA0;basis&amp;#xA0;points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(61&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 - 100&amp;#xA0;basis&amp;#xA0;points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;61&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesTableTextBlock>
  <mpw:ScheduleOfDevelopmentProjectsTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_B7555B8C-748B-40EE-8CDE-0B82F5128CFC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 8%"&gt;
 See table below for a status update on our current domestic
 development projects (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="67%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 31.95pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Operator&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 45.25pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Commitment&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Costs&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Incurred&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;as of&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 30.65pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;09/30/16&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Completion&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 39.95pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Date&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;32,684&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18,472&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4Q&amp;#xA0;2016&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,578&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,860&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1Q 2017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;69,801&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;29,616&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Ernest Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;28,067&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,054&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;201,184&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;54,154&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:ScheduleOfDevelopmentProjectsTableTextBlock>
  <mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="INF" id="id_8591822_0446D40C-5E6C-4BF3-B2B7-93B585AE747E_1_0" unitRef="pure">0.95</mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds>
  <mpw:RealEstateAndLoansReceivablesTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_73593E64-4EDF-401C-9523-0D4D52BDA3F5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;3. Real Estate and Lending Activities&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;i&gt;Acquisitions&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 We acquired the following assets (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="76%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;Nine&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Assets Acquired&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Land and land improvements&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13,874&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;113,309&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Building&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,472&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;711,805&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Intangible lease assets &amp;#x2014; subject to amortization (weighted
 average useful life of 19.4&amp;#xA0;years in 2016 and 28.4&amp;#xA0;years
 in 2015)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;10,754&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;144,900&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;365,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net investments in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;63,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;170,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;514,484&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total assets acquired&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;213,100&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,020,198&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Loans repaid (1)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(93,262&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(385,851&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total net assets acquired&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;119,838&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,634,347&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="13%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;$93.3 million loans advanced to
 Capella in 2015 and repaid in 2016 as a part of the Capella
 transaction. $385.9 million loans advanced to MEDIAN in 2014 and
 repaid in 2015 as a part of the MEDIAN transaction.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"&gt;
 The purchase price allocations attributable to certain 2016
 acquisitions and acquisitions completed in the fourth quarter of
 2015 are preliminary. When all relevant information is obtained,
 resulting changes, if any, to our provisional purchase price
 allocation will be retrospectively adjusted to reflect new
 information obtained about the facts and circumstances that existed
 as of the respective acquisition dates that, if known, would have
 affected the measurement of the amounts recognized as of those
 dates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;2016 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On July 22, 2016, we acquired an acute care facility in Olympia,
 Washington in exchange for a $93.3 million loan and an additional
 $7 million in cash, as contemplated in the August 2015 Capella
 Healthcare, Inc. (&amp;#x201C;Capella&amp;#x201D;) acquisition transaction.
 The terms of the Olympia lease are substantially similar to those
 of the master lease with Capella.&amp;#xA0;See &amp;#x201C;2015
 Activity&amp;#x201D; for a description of the August 2015 Capella
 Acquisition.&amp;#xA0;Also, see the Capella Disposal Transaction under
 the subheading &amp;#x201C;Disposals&amp;#x201D; below for further
 details.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On June&amp;#xA0;22, 2016, we closed on the final Median Kliniken
 S.&amp;#xE0; r.l., (&amp;#x201C;MEDIAN&amp;#x201D;) property for a purchase price
 of &amp;#x20AC;41.6&amp;#xA0;million. See &amp;#x201C;2015 Activity&amp;#x201D; for a
 description of the initial MEDIAN Transaction.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On May&amp;#xA0;2, 2016, we acquired an acute care hospital in Newark,
 New Jersey for an aggregate purchase price of $63 million leased to
 Prime Healthcare Services, Inc. (&amp;#x201C;Prime&amp;#x201D;) pursuant to a
 fifth master lease, which has a 15-year term with three five-year
 extension options, plus consumer-price indexed
 increases.&amp;#xA0;Furthermore, we committed to advance an additional
 $30 million to Prime over a three-year period to be used solely for
 capital additions to the real estate; any such addition will be
 added to the basis upon which the lessee will pay us rents.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 From the respective acquisition dates, the properties acquired
 during the nine months ended September 30, 2016, contributed $4.6
 million and $3.8 million of revenue and income (excluding related
 acquisition expenses), respectively, for the three months ended
 September 30, 2016. From the respective acquisition dates, the
 properties acquired during the nine months ended September 30, 2016
 contributed $5.7 million and $4.9 million of revenue and income
 (excluding related acquisition expenses), respectively, for the
 nine months ended September 30, 2016. In addition, we incurred $2.4
 million of acquisition-related costs on the 2016 acquisitions for
 the nine months ended September 30, 2016.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 On October 3, 2016, we closed on a portfolio of nine acute care
 hospitals in Massachusetts operated by Steward Health Care System
 LLC (&amp;#x201C;Steward&amp;#x201D;). Our investment in the portfolio
 includes the acquisition of five hospitals for $600 million, the
 making of $600 million in mortgage loans on four facilities and a
 $50 million minority equity contribution in Steward, for a combined
 investment of $1.25 billion.&amp;#xA0;The five facilities acquired are
 being leased to Steward under a master lease agreement that has a
 15-year term with three 5-year extension options, plus annual
 inflation-based escalators.&amp;#xA0;The terms of the mortgage loan are
 substantially similar to the master lease.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;2015 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 &lt;i&gt;Capella Acquisition&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On August&amp;#xA0;31, 2015, we closed on our acquisition of assets of
 and interests in Capella. Our investment in the Capella portfolio
 originally included seven acute care hospitals (two properties of
 which our investment was in the form of mortgage loans), an
 acquisition loan, and an equity interest in the operator for a
 combined purchase price and investment of approximately $900
 million plus Capella&amp;#x2019;s cash on hand at the acquisition
 date.&amp;#xA0;We closed on six of the seven Capella properties on
 August 31, 2015, two of which were in the form of mortgage loans,
 and we closed on the last property in the third quarter of 2016
 (see discussion of the acquisition of the Olympia, Washington
 facility above). The remaining investment in the operations of
 Capella were in the form of an acquisition loan to Capella, which
 had a fixed interest rate of 8% and 49% interest in the equity of
 the operator, with management owning the remaining 51%.&amp;#xA0;See
 subheading &amp;#x201C;Disposals&amp;#x201D; below for details of the
 disposal of our investment in Capella operations and further
 transactions.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;MEDIAN Transaction&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On April&amp;#xA0;29, 2015, we entered into a series of definitive
 agreements with MEDIAN, a German provider of post-acute and acute
 rehabilitation services, to acquire the real estate assets of 32
 hospitals owned by MEDIAN for an aggregate purchase price of
 approximately &amp;#x20AC;688 million. Upon acquisition, each property
 became subject to a master lease between us and MEDIAN providing
 for the leaseback of the property to MEDIAN. The master lease had
 an initial term of 27 years and provided for an initial GAAP lease
 rate of 9.3%, with annual escalators at the greater of one percent
 or 70% of the German consumer price index.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 MEDIAN is owned by an affiliate of Waterland Private Equity Fund V
 C.V. (&amp;#x201C;Waterland&amp;#x201D;), which acquired 94.9% of the
 outstanding equity interests in MEDIAN, and by a subsidiary of our
 operating partnership, which acquired the remaining 5.1% of the
 outstanding equity interests in MEDIAN, each in December 2014. In
 December 2014, we provided interim acquisition loans to affiliates
 of Waterland and MEDIAN in connection with Waterland&amp;#x2019;s
 acquisition of its stake in MEDIAN in an aggregate amount of
 approximately &amp;#x20AC;425 million. In addition, we made further
 loans to MEDIAN during the first half of 2015 in an aggregate
 amount of approximately &amp;#x20AC;240&amp;#xA0;million, which were used by
 MEDIAN to repay existing debt on properties we acquired.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Closing of the sale-leaseback transactions began in the second
 quarter of 2015. At each closing, the purchase price for each
 facility was reduced and offset against the interim loans made to
 affiliates of Waterland and MEDIAN as described above and against
 the amount of any debt assumed or repaid by us in connection with
 the closing. As of September&amp;#xA0;30, 2015, we had closed on 30
 properties for an aggregate amount of &amp;#x20AC;627&amp;#xA0;million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Other Acquisitions&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On September&amp;#xA0;30, 2015, we provided a $100 million mortgage
 financing (of which $85 million had been funded through September
 30, 2015 with an additional $15 million funded in the 2015 fourth
 quarter) to Prime for three general acute care hospitals and one
 free-standing emergency department and health center in New Jersey.
 The loan had a five-year term and provided for consumer-price
 indexed interest increases, subject to a floor. On October 21,
 2016, we acquired these facilities (as originally contemplated in
 the agreements) by reducing the $100 million mortgage loan and
 advancing an additional $15 million. We are leasing these
 properties to Prime pursuant to a fifth master lease.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On August&amp;#xA0;31, 2015, we closed on a $30 million mortgage loan
 transaction with Prime for the acquisition of Lake Huron Medical
 Center, a 144-bed general acute care hospital located in Port
 Huron, Michigan. The loan provided for consumer-price indexed
 interest increases, subject to a floor.&amp;#xA0;The mortgage loan had
 a 5-year term with conversion rights to our standard sale leaseback
 agreement, which we exercised for $20&amp;#xA0;million on December 31,
 2015, and reduced the mortgage loan accordingly. This facility is
 now leased to Prime pursuant to a fourth master lease.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 On June&amp;#xA0;16, 2015, we acquired the real estate of two
 facilities in Lubbock, Texas, a 60-bed inpatient rehabilitation
 hospital and a 37-bed long-term acute care hospital, for an
 aggregate purchase price of $31.5 million. We entered into a
 20-year lease with Ernest for the rehabilitation hospital, which
 provided for three five-year extension options, and separately
 entered into a lease with Ernest for the long-term acute care
 hospital that had a final term ending December&amp;#xA0;31, 2034. In
 connection with the transaction, we funded an acquisition loan to
 Ernest of approximately $12.0 million. Ernest is operating the
 rehabilitation hospital in a joint venture with Covenant Health
 System.&amp;#xA0;Effective July 18, 2016, we amended the lease of the
 rehabilitation hospital to include the long-term acute care
 hospital. Ernest&amp;#x2019;s plans are to convert the long-term acute
 care facility into a rehabilitation facility by the second quarter
 of 2017.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On February&amp;#xA0;27, 2015, we acquired an inpatient rehabilitation
 hospital in Weslaco, Texas for $10.7 million leased to Ernest
 pursuant to the 2012 master lease which had an original 20-year
 fixed term and three five-year extension options. This lease
 provided for consumer-price indexed annual rent increases, subject
 to a floor and a cap. In addition, we agreed to fund an acquisition
 loan in the amount of $5 million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On February&amp;#xA0;13, 2015, we acquired two general acute care
 hospitals in the Kansas City area for $110 million. Prime is the
 tenant and operator pursuant to a master lease that has similar
 terms and security enhancements as the other master lease
 agreements entered into in 2013. This master lease had a 10-year
 initial fixed term with two extension options of five years each.
 The lease provided for consumer-price indexed annual rent
 increases, subject to a specified floor. In addition, we agreed to
 fund a mortgage loan in the amount of $40 million, which had a
 10-year term.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 From the respective acquisition dates, the properties and mortgage
 loans acquired in 2015 contributed $30.0 million and $13.9 million
 of revenue and income (excluding related acquisition expenses),
 respectively, for the three months ended September 30, 2015. From
 the respective acquisition dates, the properties and mortgage loans
 acquired in 2015 contributed $59.2 million and $34.3 million of
 revenue and income (excluding related acquisition expenses),
 respectively, for the nine months ended September 30, 2015. In
 addition, we incurred $23.7 million and $52.9 million of
 acquisition related costs on the 2015 acquisitions for the three
 and nine months ended September 30, 2015, respectively.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Pro Forma Information&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The following unaudited supplemental pro forma operating data is
 presented for the three and nine months ended September&amp;#xA0;30,
 2016 and 2015, as if each acquisition (including the Steward
 investments completed subsequent to September&amp;#xA0;30, 2016) was
 completed on January&amp;#xA0;1, 2015. Supplemental pro forma earnings
 were adjusted to exclude acquisition-related costs on consummated
 deals incurred. The unaudited supplemental pro forma operating data
 is not necessarily indicative of what the actual results of
 operations would have been assuming the transactions had been
 completed as set forth above, nor do they purport to represent our
 results of operations for future periods (in thousands, except per
 share/unit amounts).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="72%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&lt;br /&gt;
 Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total revenues&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;162.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;156.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;479.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;480.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;73.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;63.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;206.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;227.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net income per share/unit &amp;#x2014; diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.23&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.20&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.64&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.71&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Development Activities&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"&gt;
 During the first nine months of 2016, we completed construction and
 began recording rental income on the following facilities:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="8%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Adeptus Health, Inc. (&amp;#x201C;Adeptus
 Health&amp;#x201D;) &amp;#x2013; We completed 13 acute care facilities for
 this tenant during 2016. These facilities are leased pursuant to
 the master leases entered into in both 2014 and 2015 and are
 cross-defaulted with each other and with the original master lease
 executed in 2013.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="8%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="4%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Ernest Toledo &amp;#x2013; This inpatient
 rehabilitation facility located in Toledo, Ohio opened on
 April&amp;#xA0;1, 2016 and is being leased to Ernest pursuant to the
 original 2012 master lease.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 8%"&gt;
 See table below for a status update on our current domestic
 development projects (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="67%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 31.95pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Operator&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 45.25pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Commitment&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Costs&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Incurred&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;as of&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 30.65pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;09/30/16&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Completion&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 39.95pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Date&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;32,684&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18,472&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4Q&amp;#xA0;2016&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,578&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,860&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1Q 2017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;69,801&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;29,616&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Ernest Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;28,067&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,054&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;201,184&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;54,154&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"&gt;
 On September&amp;#xA0;9, 2015, we acquired the real estate of a general
 acute care hospital under development located in Spain, for an
 aggregate purchase and development price to us of approximately
 &amp;#x20AC;21.4 million. The acquisition was effected through a joint
 venture between us and clients of AXA Real Estate, in which we own
 a 50% interest. Upon completion, the facility will be leased to a
 Spanish operator of acute care hospitals, pursuant to a long-term
 lease. We expect construction to complete on this facility in the
 second quarter of 2017.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Disposals&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;u&gt;2016 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;u&gt;Capella Disposal Transaction&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On March&amp;#xA0;21, 2016, we entered into definitive agreements with
 RegionalCare Hospital Partners, Inc. (&amp;#x201C;RegionalCare&amp;#x201D;),
 an affiliate of certain funds managed by affiliates of Apollo
 Global Management, LLC (together with its consolidated
 subsidiaries, &amp;#x201C;Apollo&amp;#x201D;), under which our investment in
 the operations of Capella would be merged with RegionalCare,
 forming RCCH Healthcare Partners (&amp;#x201C;RCCH&amp;#x201D;).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On April&amp;#xA0;29, 2016, this transaction closed and funded,
 effective April&amp;#xA0;30, 2016.&amp;#xA0;As part of the transaction, we
 received net proceeds of approximately $550 million including
 approximately $492 million for our equity investment and loans made
 as part of the original Capella acquisition that closed on
 August&amp;#xA0;31, 2015. In addition, we received $210 million in
 prepayment of two mortgage loans for hospitals in Russellville,
 Arkansas, and Lawton, Oklahoma, that we made to subsidiaries of
 Capella in connection with the Capella transaction on
 August&amp;#xA0;31, 2015. We made a new $93.3 million loan for a
 hospital property in Olympia, Washington (which was subsequently
 converted to real estate on July 22, 2016 as disclosed above).
 Additionally, we and an Apollo affiliate invested $50 million each
 in unsecured senior notes issued by RegionalCare, which we sold to
 a large institution on June 20, 2016 at par.&amp;#xA0;The proceeds from
 this transaction represented the recoverability of our investment
 in full, except for transaction costs incurred of $6.3 million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 We maintained our ownership of five Capella hospitals in Hot
 Springs, Arkansas; Camden, South Carolina; Hartsville, South
 Carolina; Muskogee, Oklahoma; and McMinnville,
 Oregon.&amp;#xA0;Pursuant to the transaction described above, the
 underlying leases, one of which is a master lease covering all but
 one property, was amended to shorten the initial fixed lease term,
 increase the security deposit, and eliminate the lessees&amp;#x2019;
 purchase option provisions. Due to this lease amendment, we
 reclassified the lease of the properties under the master lease
 from a direct financing lease (&amp;#x201C;DFL&amp;#x201D;) to an operating
 lease. This reclassification resulted in a write-off of $2.6
 million in unbilled DFL rent in the 2016 second quarter.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;Post Acute Transaction&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On May&amp;#xA0;23, 2016, we sold five properties (three of which were
 in Texas and two in Louisiana) that were leased and operated by
 Post Acute Medical (&amp;#x201C;Post Acute&amp;#x201D;). As part of this
 transaction, our outstanding loans of $4 million were paid in full,
 and we recovered our investment in the operations. Total proceeds
 from this transaction were $71 million, resulting in a net gain of
 approximately $15&amp;#xA0;million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;Corinth Transaction&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On June&amp;#xA0;17, 2016, we sold the Atrium Medical Center real
 estate located in Corinth, Texas, which was leased and operated by
 Corinth Investor Holdings. Total proceeds from the transaction were
 $28 million, resulting in a gain on the sale of real estate of
 approximately $8&amp;#xA0;million. This gain on real estate was offset
 by approximately $9 million of non-cash charges that included the
 write-off of our investment in the operations of the facility,
 straight-line rent receivables, and a lease intangible.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;u&gt;HealthSouth Transaction&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On July 20, 2016, we sold three inpatient rehabilitation hospitals
 located in Texas and operated by HealthSouth Corporation
 (&amp;#x201C;HealthSouth&amp;#x201D;) for $111.5 million, resulting in a net
 gain of approximately $45 million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;Summary of Operations for Disposed Assets in 2016&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The properties sold during the year do not meet the definition of
 discontinued operations. However, the following represents the
 operating results (excluding gain on sale, transaction costs, and
 impairment or other non-cash charges) from these properties
 (excluding loans repaid in the Capella Disposal Transaction) for
 the periods presented (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="68%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three&amp;#xA0;Months&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;Ended&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Revenues&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;244&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,523&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,851&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13,598&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Real estate depreciation and amortization&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(949&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,754&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,846&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Property-related expenses&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(10&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(114&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(82&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other income (expense)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(24&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;521&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(92&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,078&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Income from real estate dispositions, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;220&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,085&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,891&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,748&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;u&gt;2015 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On July 30, 2015, we sold a long-term acute care facility in
 Luling, Texas for approximately $9.7 million, resulting in a gain
 of $1.5 million. Due to this sale, we wrote off $0.9 million of
 straight-line receivables. On August 5, 2015, we sold six wellness
 centers in the United States for total proceeds of approximately
 $9.5 million (of which $1.5 million is in the form of a note),
 resulting in a gain of $1.7 million. Due to this sale, we wrote off
 $0.9 million of billed rent receivables. With these disposals, we
 accelerated the amortization of the related lease intangible assets
 resulting in approximately $0.7 million of additional expense in
 the 2015 third quarter.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Leasing Operations&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 All of our leases are currently accounted for as operating leases
 except for the master lease of 15 Ernest facilities and six Prime
 facilities which are accounted for as DFLs. The components of our
 net investment in DFLs (which includes the Capella properties for
 2015 only) consisted of the following (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;As&amp;#xA0;of&amp;#xA0;September&amp;#xA0;30,&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Minimum lease payments receivable&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,884,144&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,587,912&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Estimated residual values&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;292,647&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;393,097&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Less: Unearned income&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,643,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,354,013&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net investment in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;533,491&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;626,996&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;Twelve Oaks Facility&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In the third quarter of 2015, we sent notice of termination of the
 lease to the tenant at our Twelve Oaks facility due to payment
 default. As a result of terminating the lease, we recorded a charge
 of $1.9 million to write-off the straight-line rent receivables in
 the 2015 third quarter.&amp;#xA0;In addition, we accelerated the
 amortization of the related lease intangible asset resulting in
 $0.5 million of additional expense in the 2015 third quarter. This
 former tenant has continued to occupy the facility. During the
 third quarter of 2016, the tenant paid us approximately $2.5
 million representing substantially all of amounts owed to us and
 agreed to general terms of a new lease, which we expect to execute
 during the 2016 fourth quarter. The tenant is now current on all of
 its obligations to us through November 30, 2016. Although no
 assurances can be made that we will not have any impairment charges
 in the future, we believe our real estate investment in Twelve Oaks
 at September&amp;#xA0;30, 2016 is fully recoverable.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Loans&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The following is a summary of our loans (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="64%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 September&amp;#xA0;30,&amp;#xA0;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 December&amp;#xA0;31,&amp;#xA0;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;550,118&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;757,581&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Acquisition loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;122,161&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;610,469&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Working capital and other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;43,623&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;54,353&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;715,902&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,422,403&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 The decrease in our mortgage and acquisition loans are related to
 the Capella Disposal Transaction as discussed previously.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Our non-mortgage loans typically consist of loans to our tenants
 for acquisitions and working capital purposes. At
 September&amp;#xA0;30, 2016, acquisition loans include our original
 $93.2 million loan to Ernest.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On March&amp;#xA0;1, 2012, pursuant to our convertible note agreement,
 we converted $1.7 million of our $5.0 million convertible note into
 a 9.9% equity interest in the operator of our Hoboken University
 Medical Center facility. At September 30, 2016, $3.3 million
 remains outstanding on the convertible note, and we retain the
 option, subject to regulatory approvals, to convert this remainder
 into 15.1% of equity interest in the operator.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Concentrations of Credit Risk&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Our revenue concentration for the nine months ended
 September&amp;#xA0;30, 2016 as compared to the prior year is as follows
 (dollars in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Revenue by Operator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 35.05pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Operators&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Prime&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;89,389&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;75,982&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;24.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 MEDIAN&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,242&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;56,609&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Ernest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;50,564&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;45,874&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;14.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 RCCH&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;42,776&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,155&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;25,873&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.7&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12,982&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Revenue by U.S. State and Country&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="58%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 109.7pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;U.S. States and Other Countries&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Texas&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;72,811&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;63,815&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;20.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 California&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;49,724&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;49,595&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;16.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 All other states&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;189,365&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;48.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;137,006&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;44.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total U.S.&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;311,900&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;250,416&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80.7&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1pt"&gt;
 &lt;td height="8"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Germany&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;72,718&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;56,609&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 United Kingdom, Italy, and Spain&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,236&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,308&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total International&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;75,954&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,917&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Grand Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;387,854&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;310,333&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 From an asset basis, our concentration as of September&amp;#xA0;30,
 2016 as compared to December&amp;#xA0;31, 2015 is as follows (dollars
 in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Gross Assets by Operator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="49%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of September&amp;#xA0;30,
 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of December&amp;#xA0;31, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 35.05pt; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Operators&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Steward&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Prime&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,142,760&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;15.9&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,032,353&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 MEDIAN&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,054,568&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;14.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,031,039&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Ernest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;622,416&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;8.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;579,182&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 RCCH&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;564,509&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,059,989&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Gross Assets by U.S. State and Country&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="50%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of September&amp;#xA0;30,
 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of December&amp;#xA0;31, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;U.S. States and Other
 Countries&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Massachusetts&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Texas&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;944,028&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,060,990&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 California&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;542,892&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;547,085&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 All other states&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,669,401&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;37.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,047,204&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;50.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other domestic assets&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;251,587&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;177,317&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.9&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total U.S.&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,657,908&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;78.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,832,596&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;80.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1pt"&gt;
 &lt;td height="8"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Germany&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,376,626&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,031,039&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 United Kingdom, Italy, and Spain&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;156,226&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;161,317&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.7&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Other international assets&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;27,017&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.4&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;10,970&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Total International&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,559,869&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;21.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,203,326&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;19.9&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Grand Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,217,777&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,035,922&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: rgb(0,0,0) 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 2pt; WIDTH: 10%; BORDER-BOTTOM: rgb(0,0,0) 1px solid; MARGIN-TOP: 0pt; LINE-HEIGHT: 8pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Gross Assets represents total assets
 plus accumulated depreciation/amortization assuming all real estate
 commitments (such as the Steward transaction and the commitments
 disclosed in Note 9) as of the period end are fully funded.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(B)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Includes both leased and loaned
 assets.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On an individual property basis, we had no investment of any single
 property greater than 3.3% of our total gross assets as of
 September&amp;#xA0;30, 2016.&lt;/p&gt;
 &lt;/div&gt;</mpw:RealEstateAndLoansReceivablesTextBlock>
  <mpw:DebtIssuanceCost contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_1_13" unitRef="iso4217_USD">32982000</mpw:DebtIssuanceCost>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_14" unitRef="iso4217_USD">12790000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_17" unitRef="iso4217_USD">22539000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_5" unitRef="iso4217_USD">181579000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_3_3" unitRef="iso4217_USD">-92000</mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_1" unitRef="iso4217_USD">234408000</mpw:RentBilled>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_22" unitRef="iso4217_USD">139336000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:ScheduleOfLoansReceivableTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_EDC8028E-DD34-43D4-A2EF-22DCEFAA030F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The following is a summary of our loans (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="64%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 September&amp;#xA0;30,&amp;#xA0;2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 December&amp;#xA0;31,&amp;#xA0;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;550,118&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;757,581&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Acquisition loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;122,161&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;610,469&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Working capital and other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;43,623&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;54,353&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;715,902&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,422,403&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:ScheduleOfLoansReceivableTableTextBlock>
  <mpw:PercentageOfDividendsPayableOnSeniorUnsecuredNotes contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="INF" id="id_8591822_0446D40C-5E6C-4BF3-B2B7-93B585AE747E_1_1" unitRef="pure">0.95</mpw:PercentageOfDividendsPayableOnSeniorUnsecuredNotes>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_715B6A6A-9180-4FD8-BA4F-7CAA2008C9FB_1_2" unitRef="iso4217_USD">430000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_DC9F65E6-C264-4B1E-80F1-C7800F9553B9_1_7" unitRef="iso4217_USD">6757000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:LongLivedAssetsByOperatorsTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_03B8413B-218E-4357-99BC-9D7FC1D1D270_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Gross Assets by Operator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="49%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of September&amp;#xA0;30,
 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As of December&amp;#xA0;31, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 35.05pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Operators&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Gross&amp;#xA0;Assets&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(A)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;(B)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Steward&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Prime&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,142,760&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;15.9&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,032,353&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 MEDIAN&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,054,568&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;14.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,031,039&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Ernest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;622,416&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;8.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;579,182&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 RCCH&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;564,509&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,059,989&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;17.6&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:LongLivedAssetsByOperatorsTableTextBlock>
  <mpw:RevenueByOperatorTableTextBlock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" id="id_8591822_16E33B43-3A98-43F6-ADFF-C92FA625EF83_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Revenue by Operator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2016&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;the&amp;#xA0;Nine&amp;#xA0;Months&amp;#xA0;Ended&lt;br /&gt;
 September 30, 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; WIDTH: 35.05pt; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Operators&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Total&lt;br /&gt;
 Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Percentage&amp;#xA0;of&lt;br /&gt;
 Total&amp;#xA0;Revenue&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Prime&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;89,389&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;75,982&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;24.5&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 MEDIAN&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;70,242&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.1&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;56,609&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;18.2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Ernest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;50,564&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;45,874&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;14.8&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 RCCH&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;42,776&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11.0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,155&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.3&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adeptus Health&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;25,873&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.7&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12,982&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:RevenueByOperatorTableTextBlock>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_18" unitRef="iso4217_USD">-2556000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:DisposalGroupIncludingDiscontinuedOperationPropertyRelatedExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_3_2" unitRef="iso4217_USD">114000</mpw:DisposalGroupIncludingDiscontinuedOperationPropertyRelatedExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_3_2" unitRef="iso4217_USD">26509000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1329007" id="id_8591822_CC1B62DE-3832-4F70-B5A5-4504CF5B0DD3_1001_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1329007" decimals="INF" id="id_8591822_CC1B62DE-3832-4F70-B5A5-4504CF5B0DD3_1001_0" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1451778" id="id_8591822_0A483B33-E685-4786-B346-9E661E671C20_1001_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1451778" decimals="INF" id="id_8591822_0A483B33-E685-4786-B346-9E661E671C20_1001_0" unitRef="shares">799804</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1458258" id="id_8591822_64DEC6DC-1FF1-4C52-80D4-9424CA66D632_1001_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1458258" decimals="INF" id="id_8591822_64DEC6DC-1FF1-4C52-80D4-9424CA66D632_1001_0" unitRef="shares">254574</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324497x1326078" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_1001_0">Variable</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324497x1326078_1324529x1497667" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1002_6">Interest on the notes is payable  on March 1 and September 1 of each year</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
  <us-gaap:DebtInstrumentRedemptionDescription contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324497x1326078_1324529x1497667" id="id_8591822_CB1133BA-D42C-4A92-8567-D4DECF725693_1002_9">we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to March 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 106.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase.</us-gaap:DebtInstrumentRedemptionDescription>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1373522" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_2001_11">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:MaturityDateOfInterestRateSwap contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1373899_1330926x1409746" id="id_8591822_7B510C68-BDD8-4445-A34F-C05D94842724_1004_3">2016-10</mpw:MaturityDateOfInterestRateSwap>
  <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1531691" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1002_1">Interest on the notes will be payable on February 1 and August 1 of each year</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
  <us-gaap:DebtInstrumentRedemptionDescription contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1531691" id="id_8591822_FE0C878B-E464-407F-A522-3621CF550B4A_1002_6">We may redeem some or all of the notes at any time prior to August 1, 2021 at a &#x201C;make whole&#x201D; redemption price. On or after August 1, 2021, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to August 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 105.25% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase.</us-gaap:DebtInstrumentRedemptionDescription>
  <mpw:NumberOfDirectFinancingLeases contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1353451_1334994x1354729" decimals="INF" id="id_8591822_3FE80C16-9F96-429D-84DD-4BC0A54064C4_1002_0" unitRef="Leases">6</mpw:NumberOfDirectFinancingLeases>
  <mpw:NumberOfDirectFinancingLeases contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1353451_1334994x1393133" decimals="INF" id="id_8591822_3FE80C16-9F96-429D-84DD-4BC0A54064C4_1001_0" unitRef="Leases">15</mpw:NumberOfDirectFinancingLeases>
  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1430282_1333690x1500705" decimals="-5" id="id_8591822_0EF3FFF6-7478-4B8F-A6F2-4E51F98AECC1_1001_0" unitRef="iso4217_USD">5700000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1430282_1333690x1500705" decimals="-5" id="id_8591822_0EF3FFF6-7478-4B8F-A6F2-4E51F98AECC1_1001_1" unitRef="iso4217_USD">2400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <mpw:OperatingLeasesIncomeStatementLeaseIncome contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1430282_1333690x1500705" decimals="-5" id="id_8591822_0EF3FFF6-7478-4B8F-A6F2-4E51F98AECC1_1001_2" unitRef="iso4217_USD">4900000</mpw:OperatingLeasesIncomeStatementLeaseIncome>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1001_10">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1001_9">2016</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1001_6">10-Q</dei:DocumentType>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_35" unitRef="iso4217_USD_per_shares">0.75</us-gaap:EarningsPerShareDiluted>
  <dei:EntityCentralIndexKey contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1001_7">0001524607</dei:EntityCentralIndexKey>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_33" unitRef="iso4217_USD_per_shares">0.75</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_8" unitRef="shares">241432000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_6" unitRef="shares">240607000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <dei:AmendmentFlag contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1001_7">false</dei:AmendmentFlag>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_28" unitRef="iso4217_USD_per_shares">0.75</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="INF" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_37" unitRef="iso4217_USD_per_shares">0.68</us-gaap:CommonStockDividendsPerShareDeclared>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1001_8">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentPeriodEndDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_CEB05EEB-63A3-46FC-B95F-96A76AA2A9FB_1001_8">2016-09-30</dei:DocumentPeriodEndDate>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_30" unitRef="iso4217_USD_per_shares">0.75</us-gaap:EarningsPerShareBasic>
  <dei:EntityFilerCategory contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1001_9">Non-accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_7" unitRef="shares">825000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_16" unitRef="iso4217_USD">168289000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PartnersCapitalAccountUnitsSaleOfUnits contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-4" id="id_8591822_435CBC63-694B-496A-8248-2F3D0A23379B_1001_0" unitRef="shares">72500000</us-gaap:PartnersCapitalAccountUnitsSaleOfUnits>
  <dei:EntityRegistrantName contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" id="id_8591822_B3BEA9E9-F75A-4C2A-9C86-4894D3E59DEE_1001_6">MPT OPERATING PARTNERSHIP, L.P.</dei:EntityRegistrantName>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_5" unitRef="iso4217_USD">387854000</us-gaap:Revenues>
  <us-gaap:PaymentsForProceedsFromLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_21" unitRef="iso4217_USD">102909000</us-gaap:PaymentsForProceedsFromLoansReceivable>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1003_3" unitRef="iso4217_USD">10354000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_4" unitRef="iso4217_USD">79756000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_42" unitRef="iso4217_USD">17458000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_4" unitRef="iso4217_USD">27009000</us-gaap:StraightLineRent>
  <us-gaap:PaymentsToAcquireNotesReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_23" unitRef="iso4217_USD">50000000</us-gaap:PaymentsToAcquireNotesReceivable>
  <us-gaap:PaymentsToAcquireOtherInvestments contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_25" unitRef="iso4217_USD">52701000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_31" unitRef="iso4217_USD">160060000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_13" unitRef="iso4217_USD">268917000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_26" unitRef="iso4217_USD">182009000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_40" unitRef="iso4217_USD">120374000</us-gaap:InterestPaid>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_23" unitRef="iso4217_USD">-1000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_16" unitRef="iso4217_USD">61294000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1003_4" unitRef="iso4217_USD">195540000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1003_6" unitRef="iso4217_USD">194857000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_3" unitRef="iso4217_USD">47181000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_30" unitRef="iso4217_USD">515221000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_24" unitRef="iso4217_USD">182692000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_4" unitRef="iso4217_USD">-1000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_0" unitRef="iso4217_USD">182693000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_9" unitRef="iso4217_USD">61294000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_18" unitRef="iso4217_USD">213100000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_19" unitRef="iso4217_USD">-118000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_12" unitRef="iso4217_USD">8398000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1003_2" unitRef="iso4217_USD">2494000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_21" unitRef="iso4217_USD">-86224000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_3" unitRef="iso4217_USD">69720000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_1" unitRef="iso4217_USD">683000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_20" unitRef="iso4217_USD">1173000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_15" unitRef="iso4217_USD">121132000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_32" unitRef="iso4217_USD">1024088000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_8" unitRef="iso4217_USD">5832000</us-gaap:ShareBasedCompensation>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_8" unitRef="iso4217_USD">7295000</us-gaap:AssetImpairmentCharges>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_10" unitRef="iso4217_USD">6379000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_7" unitRef="iso4217_USD">67850000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_9" unitRef="iso4217_USD">1592000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ImpairmentOfRealEstate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_5" unitRef="iso4217_USD">3063000</us-gaap:ImpairmentOfRealEstate>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_26" unitRef="iso4217_USD">495530000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_34" unitRef="iso4217_USD">-31317000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_10" unitRef="iso4217_USD">5799000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_12" unitRef="iso4217_USD">118937000</us-gaap:CostsAndExpenses>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_37" unitRef="iso4217_USD">4283000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_11" unitRef="iso4217_USD">35821000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_25" unitRef="iso4217_USD">683000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_20" unitRef="iso4217_USD">804809000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_28" unitRef="iso4217_USD">-1100000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_36" unitRef="iso4217_USD">895093000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1003_5" unitRef="iso4217_USD">683000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_15" unitRef="iso4217_USD">-12403000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_35" unitRef="iso4217_USD">231274000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_29" unitRef="iso4217_USD">1000000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromSaleOfNotesReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_24" unitRef="iso4217_USD">50000000</us-gaap:ProceedsFromSaleOfNotesReceivable>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_19" unitRef="iso4217_USD">198767000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_3" unitRef="iso4217_USD">181580000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:NumberOfOtherPartners contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="INF" id="id_8591822_A0780882-F0A9-41EB-A43B-6BEDD056DE4A_1001_1" unitRef="Partner">3</mpw:NumberOfOtherPartners>
  <mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_33" unitRef="iso4217_USD">-13784000</mpw:PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_14" unitRef="iso4217_USD">12790000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_17" unitRef="iso4217_USD">22539000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_5" unitRef="iso4217_USD">181579000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_1" unitRef="iso4217_USD">234408000</mpw:RentBilled>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_22" unitRef="iso4217_USD">139336000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_103D4781-D72F-4202-B50D-80F845287701_1001_2" unitRef="iso4217_USD">430000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9A406C96-738A-486C-9764-2CA9A907ECB3_1001_7" unitRef="iso4217_USD">6757000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_18" unitRef="iso4217_USD">-2556000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1003_2" unitRef="iso4217_USD">26509000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330096x1487397" decimals="-5" id="id_8591822_55D05A39-DA4C-4FD7-B4EB-9CDF85556F7A_1001_2" unitRef="iso4217_USD">799500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330096x1487397" decimals="-5" id="id_8591822_55D05A39-DA4C-4FD7-B4EB-9CDF85556F7A_1001_1" unitRef="shares">7500000</mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1325518_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4001_2" unitRef="pure">0.173</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330589_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4003_2" unitRef="pure">0.075</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330589_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2002_2" unitRef="pure">0.128</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330589_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2002_1" unitRef="iso4217_USD">49724000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330786_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4007_2" unitRef="pure">0.191</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330786_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2005_2" unitRef="pure">0.188</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330786_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2005_1" unitRef="iso4217_USD">72718000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336058_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4002_2" unitRef="pure">0.131</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336058_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2001_2" unitRef="pure">0.188</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336058_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2001_1" unitRef="iso4217_USD">72811000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336103_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4006_2" unitRef="pure">0.784</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336103_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2004_2" unitRef="pure">0.804</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336103_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2004_1" unitRef="iso4217_USD">311900000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1377380_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4004_2" unitRef="pure">0.370</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1377380_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2003_2" unitRef="pure">0.488</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1377380_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2003_1" unitRef="iso4217_USD">189365000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1378289_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4010_2" unitRef="pure">0.216</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1378289_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2007_2" unitRef="pure">0.196</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1378289_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2007_1" unitRef="iso4217_USD">75954000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1402629_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4008_2" unitRef="pure">0.021</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1402629_1333817x1383489_1333818x1327561" decimals="3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2006_2" unitRef="pure">0.008</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1402629_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2006_1" unitRef="iso4217_USD">3236000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1529443_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4005_2" unitRef="pure">0.035</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1529444_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4009_2" unitRef="pure">0.004</us-gaap:ConcentrationRiskPercentage1>
  <mpw:NumberOfPartnersSharedRemainingOwnershipPercentage contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330194x1334098" decimals="INF" id="id_8591822_A0780882-F0A9-41EB-A43B-6BEDD056DE4A_2001_3" unitRef="Director">1</mpw:NumberOfPartnersSharedRemainingOwnershipPercentage>
  <mpw:NumberOfPartnersSharedRemainingOwnershipPercentage contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330194x1352081" decimals="INF" id="id_8591822_A0780882-F0A9-41EB-A43B-6BEDD056DE4A_3001_2" unitRef="Employee">2</mpw:NumberOfPartnersSharedRemainingOwnershipPercentage>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330926x1328370" decimals="INF" id="id_8591822_5F3CFCB6-C580-4E87-8429-24B2A6D3A6FB_1003_0" unitRef="iso4217_USD">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1331210x1383355" decimals="-3" id="id_8591822_3EE38258-CFB6-4BD4-A297-6EB585FF0FC9_1_1" unitRef="iso4217_USD">-61000</mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument>
  <mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1331210x1514918" decimals="-3" id="id_8591822_3EE38258-CFB6-4BD4-A297-6EB585FF0FC9_2_1" unitRef="iso4217_USD">61000</mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561" decimals="INF" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_4011_2" unitRef="pure">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1393133" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_4004_2" unitRef="pure">0.086</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1455637" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_4003_2" unitRef="pure">0.146</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1491880" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_4002_2" unitRef="pure">0.159</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1531683" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_4005_2" unitRef="pure">0.078</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1534840" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_4001_2" unitRef="pure">0.173</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561" decimals="INF" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2008_2" unitRef="pure">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561" decimals="-3" id="id_8591822_D0424A2D-FA27-42EF-9A23-E9F5D13F2A5A_2008_1" unitRef="iso4217_USD">387854000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1393133" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2003_2" unitRef="pure">0.130</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1393133" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2003_1" unitRef="iso4217_USD">50564000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1412130" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2005_2" unitRef="pure">0.067</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1412130" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2005_1" unitRef="iso4217_USD">25873000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1455637" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2002_2" unitRef="pure">0.181</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1455637" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2002_1" unitRef="iso4217_USD">70242000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1491880" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2001_2" unitRef="pure">0.231</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1491880" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2001_1" unitRef="iso4217_USD">89389000</us-gaap:Revenues>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1531683" decimals="3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2004_2" unitRef="pure">0.110</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1531683" decimals="-3" id="id_8591822_2F229A55-F913-4F1C-8999-D3753B2B1163_2004_1" unitRef="iso4217_USD">42776000</us-gaap:Revenues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334258x1485840" decimals="-6" id="id_8591822_3993D3D3-516B-46AA-B646-C6ACB3E36F13_2_3" unitRef="iso4217_USD">224000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mpw:SalesCommissionAmount contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334258x1485840" decimals="-5" id="id_8591822_3993D3D3-516B-46AA-B646-C6ACB3E36F13_2_4" unitRef="iso4217_USD">2800000</mpw:SalesCommissionAmount>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1393133" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_4_2" unitRef="iso4217_USD">3206000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1393133" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_4_3">3Q 2017</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529440" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_1_2" unitRef="iso4217_USD">18472000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529440" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_1_3">4Q 2016</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529441" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2_2" unitRef="iso4217_USD">2860000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529441" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_2_3">1Q 2017</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529442" decimals="-3" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_3_2" unitRef="iso4217_USD">29616000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529442" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_3_3">2Q 2017</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1531679" id="id_8591822_B5941B4D-1400-4914-92D0-4C1915C0493D_5_3">Various</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="eol_PE631979--1610-Q0008_STD_274_20160930_0_1335427x1487449" id="id_8591822_861156A3-6163-4EDD-83B5-446CB32DDA4F_1001_3">P19Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
  <mpw:DebtIssuanceCost contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0" decimals="-3" id="id_8591822_E130DC94-4A77-40FD-B7F5-9263C8672091_2_13" unitRef="iso4217_USD">28367000</mpw:DebtIssuanceCost>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1324497x1326078" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_1002_0">Variable</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1324529x1373522" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_2002_11">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1324529x1535294" id="id_8591822_144C5798-FC62-48DB-8837-11110602575D_3002_1">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1325953x1439200_1334994x1519445" decimals="-6" id="id_8591822_704D825B-629C-4EE1-A3E0-D09FD026CA89_2002_3" unitRef="iso4217_USD">20000000</us-gaap:AcquisitionCosts>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1330589_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2003_4" unitRef="pure">0.091</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1330786_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2007_4" unitRef="pure">0.171</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1336058_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2002_4" unitRef="pure">0.176</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1336103_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2006_4" unitRef="pure">0.801</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1377380_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2004_4" unitRef="pure">0.505</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1378289_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2010_4" unitRef="pure">0.199</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1402629_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2008_4" unitRef="pure">0.027</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1529443_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2005_4" unitRef="pure">0.029</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1529444_1333817x1327273_1333818x1327561" decimals="3" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2009_4" unitRef="pure">0.001</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561" decimals="INF" id="id_8591822_2A69C11D-EE5D-42C9-8F33-0337922698FB_2011_4" unitRef="pure">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1393133" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_2004_4" unitRef="pure">0.096</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1455637" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_2003_4" unitRef="pure">0.171</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1491880" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_2002_4" unitRef="pure">0.171</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1531683" decimals="3" id="id_8591822_12B5FE15-7CC7-4286-9677-AD5F326C4C20_2005_4" unitRef="pure">0.176</us-gaap:ConcentrationRiskPercentage1>
  <mpw:UnbilledDirectFinanceLeaseRentWriteOff contextRef="eol_PE631979--1610-Q0008_STD_91_20160630_0_1326002x1439614" decimals="-5" id="id_8591822_240DF095-F001-41FE-9CF4-4E99D01BAAB7_2_1" unitRef="iso4217_USD">2600000</mpw:UnbilledDirectFinanceLeaseRentWriteOff>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_35" unitRef="iso4217_USD_per_shares">0.10</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_33" unitRef="iso4217_USD_per_shares">0.10</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_8" unitRef="shares">223948000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_6" unitRef="shares">223948000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_28" unitRef="iso4217_USD_per_shares">0.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_2_2" unitRef="iso4217_USD_per_shares">0.20</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="INF" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_37" unitRef="iso4217_USD_per_shares">0.22</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_30" unitRef="iso4217_USD_per_shares">0.10</us-gaap:EarningsPerShareBasic>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_5" unitRef="iso4217_USD">114570000</us-gaap:Revenues>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_2_3" unitRef="iso4217_USD">-573000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_4" unitRef="iso4217_USD">24497000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_2_0" unitRef="iso4217_USD">4523000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_2_4" unitRef="iso4217_USD">4085000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_13" unitRef="iso4217_USD">57100000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_26" unitRef="iso4217_USD">23057000</us-gaap:NetIncomeLoss>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_16" unitRef="iso4217_USD">3268000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_2_4" unitRef="iso4217_USD">23277000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_2_6" unitRef="iso4217_USD">23211000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_3" unitRef="iso4217_USD">14692000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_24" unitRef="iso4217_USD">23123000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_0" unitRef="iso4217_USD">23123000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_2_1" unitRef="iso4217_USD">63000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_19" unitRef="iso4217_USD">-1918000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_2_2" unitRef="iso4217_USD">727000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_21" unitRef="iso4217_USD">-33977000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_2_0" unitRef="iso4217_USD">156500</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_1" unitRef="iso4217_USD">66000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_20" unitRef="iso4217_USD">80000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_15" unitRef="iso4217_USD">31643000</us-gaap:InterestExpense>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_10" unitRef="iso4217_USD">24949000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_7" unitRef="iso4217_USD">20016000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_9" unitRef="iso4217_USD">1727000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_12" unitRef="iso4217_USD">57470000</us-gaap:CostsAndExpenses>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_11" unitRef="iso4217_USD">10778000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_25" unitRef="iso4217_USD">66000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_2_5" unitRef="iso4217_USD">66000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_2_1" unitRef="iso4217_USD">949000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_3" unitRef="iso4217_USD">22792000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:LineOfCreditFacilityAmendmentFeesIncurred contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-5" id="id_8591822_FE5F7E7A-74F2-4AC2-8B17-975477CE85A2_2_4" unitRef="iso4217_USD">100000</mpw:LineOfCreditFacilityAmendmentFeesIncurred>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_17" unitRef="iso4217_USD">4080000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_5" unitRef="iso4217_USD">22792000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_2_3" unitRef="iso4217_USD">521000</mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_1" unitRef="iso4217_USD">70358000</mpw:RentBilled>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_2_2" unitRef="iso4217_USD">265000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_18" unitRef="iso4217_USD">476000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:DisposalGroupIncludingDiscontinuedOperationPropertyRelatedExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_2_2" unitRef="iso4217_USD">10000</mpw:DisposalGroupIncludingDiscontinuedOperationPropertyRelatedExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_2_2" unitRef="iso4217_USD">5023000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325942x1455126" decimals="-5" id="id_8591822_AE1D5722-6F4E-46B2-89AA-C305907396F1_1003_3" unitRef="iso4217_USD">500000</us-gaap:AmortizationOfIntangibleAssets>
  <mpw:DisposalGroupIncludingDiscontinuedOperationLossGainOnWriteDown contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325942x1455126" decimals="-5" id="id_8591822_AE1D5722-6F4E-46B2-89AA-C305907396F1_1003_2" unitRef="iso4217_USD">1900000</mpw:DisposalGroupIncludingDiscontinuedOperationLossGainOnWriteDown>
  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325953x1439200_1333690x1500705" decimals="-5" id="id_8591822_7E0DF3BD-5272-4E0F-839E-92B5749D6472_1001_0" unitRef="iso4217_USD">30000000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325953x1439200_1333690x1500705" decimals="-5" id="id_8591822_7E0DF3BD-5272-4E0F-839E-92B5749D6472_1001_2" unitRef="iso4217_USD">23700000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <mpw:OperatingLeasesIncomeStatementLeaseIncome contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325953x1439200_1333690x1500705" decimals="-5" id="id_8591822_7E0DF3BD-5272-4E0F-839E-92B5749D6472_1001_1" unitRef="iso4217_USD">13900000</mpw:OperatingLeasesIncomeStatementLeaseIncome>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_35" unitRef="iso4217_USD_per_shares">0.10</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_33" unitRef="iso4217_USD_per_shares">0.10</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_8" unitRef="shares">223948000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_6" unitRef="shares">223948000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_28" unitRef="iso4217_USD_per_shares">0.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="INF" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_37" unitRef="iso4217_USD_per_shares">0.22</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_30" unitRef="iso4217_USD_per_shares">0.10</us-gaap:EarningsPerShareBasic>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_5" unitRef="iso4217_USD">114570000</us-gaap:Revenues>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1002_3" unitRef="iso4217_USD">-573000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_4" unitRef="iso4217_USD">24497000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_13" unitRef="iso4217_USD">57100000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_26" unitRef="iso4217_USD">23057000</us-gaap:NetIncomeLoss>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_16" unitRef="iso4217_USD">3268000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1002_4" unitRef="iso4217_USD">23277000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1002_6" unitRef="iso4217_USD">23211000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_3" unitRef="iso4217_USD">14692000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_24" unitRef="iso4217_USD">23123000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_0" unitRef="iso4217_USD">23123000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_19" unitRef="iso4217_USD">-1918000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1002_2" unitRef="iso4217_USD">727000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_21" unitRef="iso4217_USD">-33977000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_1" unitRef="iso4217_USD">66000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_20" unitRef="iso4217_USD">80000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_15" unitRef="iso4217_USD">31643000</us-gaap:InterestExpense>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_10" unitRef="iso4217_USD">24949000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_7" unitRef="iso4217_USD">20016000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_9" unitRef="iso4217_USD">1727000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_12" unitRef="iso4217_USD">57470000</us-gaap:CostsAndExpenses>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_11" unitRef="iso4217_USD">10778000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_25" unitRef="iso4217_USD">66000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1002_5" unitRef="iso4217_USD">66000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_3" unitRef="iso4217_USD">22792000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_17" unitRef="iso4217_USD">4080000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_5" unitRef="iso4217_USD">22792000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_1" unitRef="iso4217_USD">70358000</mpw:RentBilled>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1002_2" unitRef="iso4217_USD">265000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_18" unitRef="iso4217_USD">476000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1002_2" unitRef="iso4217_USD">5023000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1330098x1336103" decimals="-5" id="id_8591822_2207D77D-436E-4C75-9A2B-5929B0B98812_2003_8" unitRef="iso4217_USD">700000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1330926x1328370" decimals="INF" id="id_8591822_5F3CFCB6-C580-4E87-8429-24B2A6D3A6FB_1002_0" unitRef="iso4217_USD">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:PaymentsForUnderwritingExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20150930_0_1333690x1439614" decimals="-5" id="id_8591822_637715FC-7217-4E1C-A81F-892D9A1C92EF_1002_1" unitRef="iso4217_USD">3900000</us-gaap:PaymentsForUnderwritingExpense>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_35" unitRef="iso4217_USD_per_shares">0.28</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_33" unitRef="iso4217_USD_per_shares">0.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_8" unitRef="shares">247468000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_6" unitRef="shares">246230000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_28" unitRef="iso4217_USD_per_shares">0.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="0" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_1_2" unitRef="iso4217_USD_per_shares">0.23</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="INF" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_37" unitRef="iso4217_USD_per_shares">0.23</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="2" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_30" unitRef="iso4217_USD_per_shares">0.29</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_7" unitRef="shares">1238000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_5" unitRef="iso4217_USD">126555000</us-gaap:Revenues>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_1_3" unitRef="iso4217_USD">4450000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_4" unitRef="iso4217_USD">19749000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_1_0" unitRef="iso4217_USD">244000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_1_4" unitRef="iso4217_USD">220000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_13" unitRef="iso4217_USD">87870000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_26" unitRef="iso4217_USD">70358000</us-gaap:NetIncomeLoss>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_16" unitRef="iso4217_USD">44616000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_1_4" unitRef="iso4217_USD">75847000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_1_6" unitRef="iso4217_USD">75662000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_3" unitRef="iso4217_USD">14678000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_24" unitRef="iso4217_USD">70543000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_0" unitRef="iso4217_USD">70543000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_1_1" unitRef="iso4217_USD">73300</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_19" unitRef="iso4217_USD">99000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_1_2" unitRef="iso4217_USD">854000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_21" unitRef="iso4217_USD">-17327000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-2" id="id_8591822_CDEA1801-BFAA-4936-AFDC-3A4BDD19BC4F_1_0" unitRef="iso4217_USD">162400</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_1" unitRef="iso4217_USD">185000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_20" unitRef="iso4217_USD">490000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_15" unitRef="iso4217_USD">40262000</us-gaap:InterestExpense>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_8" unitRef="iso4217_USD">-80000</us-gaap:AssetImpairmentCharges>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_10" unitRef="iso4217_USD">2677000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_7" unitRef="iso4217_USD">23876000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_9" unitRef="iso4217_USD">-93000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_12" unitRef="iso4217_USD">38685000</us-gaap:CostsAndExpenses>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_11" unitRef="iso4217_USD">12305000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_25" unitRef="iso4217_USD">185000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_5594B9A7-776C-4AD3-8AD7-463789A452DB_1_5" unitRef="iso4217_USD">185000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_3" unitRef="iso4217_USD">70204000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_17" unitRef="iso4217_USD">22535000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_5" unitRef="iso4217_USD">70204000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_BDCC07E1-8A1D-49B5-9BD1-7B8613EEE9BC_1_3" unitRef="iso4217_USD">-24000</mpw:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_1" unitRef="iso4217_USD">82387000</mpw:RentBilled>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_F3A451EE-3615-4B11-9FF6-39E2A9DA37FE_1_2" unitRef="iso4217_USD">154000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_18" unitRef="iso4217_USD">1245000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0" decimals="-3" id="id_8591822_973A6097-93C9-4B90-94AB-BC465C2A5A9C_1_2" unitRef="iso4217_USD">9741000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:RedemptionPremium contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1324529x1435109" decimals="-5" id="id_8591822_81376E7E-70FF-489C-BF07-06C30E84A74E_1001_2" unitRef="iso4217_USD">15500000</us-gaap:RedemptionPremium>
  <mpw:DebtRefinancingCharge contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1324529x1435109" decimals="-5" id="id_8591822_81376E7E-70FF-489C-BF07-06C30E84A74E_1001_1" unitRef="iso4217_USD">22500000</mpw:DebtRefinancingCharge>
  <mpw:NotesRedeemedValue contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1324529x1435109" decimals="-6" id="id_8591822_81376E7E-70FF-489C-BF07-06C30E84A74E_1001_0" unitRef="iso4217_USD">450000000</mpw:NotesRedeemedValue>
  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1325953x1430282_1333690x1500705" decimals="-5" id="id_8591822_0EF3FFF6-7478-4B8F-A6F2-4E51F98AECC1_1002_0" unitRef="iso4217_USD">4600000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>
  <mpw:OperatingLeasesIncomeStatementLeaseIncome contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1325953x1430282_1333690x1500705" decimals="-5" id="id_8591822_0EF3FFF6-7478-4B8F-A6F2-4E51F98AECC1_1002_2" unitRef="iso4217_USD">3800000</mpw:OperatingLeasesIncomeStatementLeaseIncome>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_35" unitRef="iso4217_USD_per_shares">0.28</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_33" unitRef="iso4217_USD_per_shares">0.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_34" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_8" unitRef="shares">247468000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_6" unitRef="shares">246230000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_28" unitRef="iso4217_USD_per_shares">0.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="0" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_29" unitRef="iso4217_USD_per_shares">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="INF" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_37" unitRef="iso4217_USD_per_shares">0.23</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="2" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_30" unitRef="iso4217_USD_per_shares">0.29</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_7" unitRef="shares">1238000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:Revenues contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_5" unitRef="iso4217_USD">126555000</us-gaap:Revenues>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1001_3" unitRef="iso4217_USD">4450000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_4" unitRef="iso4217_USD">19749000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_13" unitRef="iso4217_USD">87870000</us-gaap:OperatingIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_26" unitRef="iso4217_USD">70358000</us-gaap:NetIncomeLoss>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_16" unitRef="iso4217_USD">44616000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1001_4" unitRef="iso4217_USD">75847000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1001_6" unitRef="iso4217_USD">75662000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_3" unitRef="iso4217_USD">14678000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_24" unitRef="iso4217_USD">70543000</us-gaap:ProfitLoss>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_0" unitRef="iso4217_USD">70543000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_19" unitRef="iso4217_USD">99000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1001_2" unitRef="iso4217_USD">854000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_21" unitRef="iso4217_USD">-17327000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_1" unitRef="iso4217_USD">185000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_20" unitRef="iso4217_USD">490000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_15" unitRef="iso4217_USD">40262000</us-gaap:InterestExpense>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_8" unitRef="iso4217_USD">-80000</us-gaap:AssetImpairmentCharges>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_10" unitRef="iso4217_USD">2677000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_7" unitRef="iso4217_USD">23876000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_9" unitRef="iso4217_USD">-93000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_12" unitRef="iso4217_USD">38685000</us-gaap:CostsAndExpenses>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_11" unitRef="iso4217_USD">12305000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_25" unitRef="iso4217_USD">185000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_5FF4B3F8-A573-4511-9C10-D990E6681A64_1001_5" unitRef="iso4217_USD">185000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_3" unitRef="iso4217_USD">70204000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:DebtRefinancingAndUnutilizedFinancingExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_17" unitRef="iso4217_USD">22535000</mpw:DebtRefinancingAndUnutilizedFinancingExpense>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_5" unitRef="iso4217_USD">70204000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_1" unitRef="iso4217_USD">82387000</mpw:RentBilled>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_9F0777D9-BED6-41C9-88EF-8443EC50F59C_1001_2" unitRef="iso4217_USD">154000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:EarningsFromEquityAndOtherInterestsExpense contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_18" unitRef="iso4217_USD">1245000</mpw:EarningsFromEquityAndOtherInterestsExpense>
  <mpw:StraightLineRentRevenueNetOfWriteOffs contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026" decimals="-3" id="id_8591822_6CB84B82-44A1-4DAA-89F4-A48103B2F532_1001_2" unitRef="iso4217_USD">9741000</mpw:StraightLineRentRevenueNetOfWriteOffs>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="eol_PE631979--1610-Q0008_STD_92_20160930_0_1330926x1328370" decimals="INF" id="id_8591822_5F3CFCB6-C580-4E87-8429-24B2A6D3A6FB_1001_0" unitRef="iso4217_USD">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:MortgageLoansOnRealEstateCollectionsOfPrincipal contextRef="eol_PE631979--1610-Q0008_STD_92_20151231_0_1325953x1439200_1328644x1440213" decimals="-6" id="id_8591822_398CC972-2379-45F3-BEB8-482EA59390E0_1002_4" unitRef="iso4217_USD">15000000</us-gaap:MortgageLoansOnRealEstateCollectionsOfPrincipal>
  <mpw:NumberOfPropertiesClosedOn contextRef="eol_PE631979--1610-Q0008_STD_92_20151231_0_1325953x1439200_1333690x1439614" decimals="INF" id="id_8591822_F1631A6B-D4CC-4E5D-82CE-ED2B65F2DA79_1002_3" unitRef="Property">6</mpw:NumberOfPropertiesClosedOn>
  <context id="eol_PE631979--1610-Q0008_STD_92_20151231_0_1325953x1439200_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-10-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20151231_0_1325953x1439200_1328644x1440213">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:GeneralAcuteCareHospitalAndHealthcareSystemMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-10-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20160930_0_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20160930_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20160930_0_1325953x1430282_1333690x1500705">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:BusinessAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20160930_0_1324529x1435109">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandElevenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20160930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2016-07-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0_1330098x1336103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325953x1439200_1333690x1500705">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:BusinessAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0_1325942x1455126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mpw:TwelveOaksFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_92_20150930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_91_20160630_0_1326002x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1531683">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:RCCHHealthcarePartnersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1491880">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1529444_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherInternationalStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1529443_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherDomesticMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1402629_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:ItalySpainAndUnitedKingdomMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1378289_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1377380_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherUnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1336103_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1336058_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1330786_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1330098x1330589_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1325953x1439200_1334994x1519445">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:LakeHuronMedicalCenterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1324529x1535294">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesDueTwoThousandSixteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1324529x1373522">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TermLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0_1324497x1326078">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_365_20151231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1335427x1487449">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1531679">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529442">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529441">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1529440">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1334258x1485840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1531683">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:RCCHHealthcarePartnersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1491880">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1412130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1534840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:StewardMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1531683">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:RCCHHealthcarePartnersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1491880">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1331210x1514918">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">mpw:MinusHundredBasisPointsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1331210x1383355">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">mpw:PlusHundredBasisPointsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330194x1352081">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mpw:EmployeeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330194x1334098">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1529444_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherInternationalStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1529443_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherDomesticMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1402629_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:ItalySpainAndUnitedKingdomMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1402629_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:ItalySpainAndUnitedKingdomMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1378289_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1378289_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1377380_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherUnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1377380_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherUnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336103_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336103_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336058_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1336058_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330786_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330786_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330589_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1330589_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330098x1325518_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1330096x1487397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1430282_1333690x1500705">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:BusinessAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1353451_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:LeasingOperationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1325953x1353451_1334994x1354729">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeFacilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:LeasingOperationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1531691">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandTwentySixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1373899_1330926x1409746">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mpw:InterestRateContractTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324529x1373522">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TermLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324497x1326078_1324529x1497667">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixteenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324497x1326078">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1458258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:TimeBasedAwardsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1451778">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:MultiYearPerformanceBasedAwardsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0_1324199x1329007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_274_20160930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1335427x1487449">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1531683">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:RCCHHealthcarePartnersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1491880">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1412130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1402629_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:ItalySpainAndUnitedKingdomMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1378289_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1377380_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherUnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1336103_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1336058_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1330786_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1330098x1330589_1333817x1383489_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">mpw:RevenueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1325953x1439200_1333690x1500705">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:BusinessAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1324199x1458258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:TimeBasedAwardsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1324199x1451778">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:MultiYearPerformanceBasedAwardsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0_1324199x1329007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_273_20150930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_182_20160630_0_1326002x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150114_0_1330096x1487397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-01-14</startDate>
      <endDate>2015-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20161007_0_1326002x1433225_1330097x1333806_1330125x1329075_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:CerberusCapitalManagementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-10-07</startDate>
      <endDate>2016-10-07</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:StewardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-10-03</startDate>
      <endDate>2016-10-03</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20161001_0_1330098x1330786_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-10-01</startDate>
      <endDate>2016-10-01</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160928_0_1330098x1534851">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:WashingtonAndIdahoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-09-28</startDate>
      <endDate>2016-09-28</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160909_0_1330098x1330786">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-09-09</startDate>
      <endDate>2016-09-09</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1328644x1440213">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:GeneralAcuteCareHospitalAndHealthcareSystemMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-09-30</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150930_0_1325953x1439200_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-09-30</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150909_0_1325953x1439200_1328480x1409831_1328644x1358103_1330098x1334274">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:AxaRealEstateMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:ES</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-09-09</startDate>
      <endDate>2015-09-09</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150831_0_1325953x1439200_1334994x1519445">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:LakeHuronMedicalCenterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-08-31</startDate>
      <endDate>2015-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150831_0_1325953x1439200_1328644x1502927_1334994x1519445">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:LakeHuronMedicalCenterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:GeneralAcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-08-31</startDate>
      <endDate>2015-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691_1335482x1328677">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandTwentySixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-22</startDate>
      <endDate>2016-07-22</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160722_0_1324529x1531691">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandTwentySixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-22</startDate>
      <endDate>2016-07-22</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160720_0_1330098x1330786">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-20</startDate>
      <endDate>2016-07-20</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160720_0_1326002x1531688_1330098x1336058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:HealthSouthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-20</startDate>
      <endDate>2016-07-20</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160720_0_1326002x1531688">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:HealthSouthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-07-20</startDate>
      <endDate>2016-07-20</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160622_0_1325953x1430282_1330098x1535290_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OlympiaWashingtonMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-06-22</startDate>
      <endDate>2016-06-22</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160617_0_1326002x1529494_1330098x1336058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:PostAcuteMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-06-17</startDate>
      <endDate>2016-06-17</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160617_0_1326002x1529494">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:PostAcuteMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-06-17</startDate>
      <endDate>2016-06-17</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150730_0_1330098x1336058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-07-30</startDate>
      <endDate>2015-07-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-06-16</startDate>
      <endDate>2015-06-16</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1328644x1366429_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:RehabilitationHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-06-16</startDate>
      <endDate>2015-06-16</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150616_0_1325953x1439200_1328644x1358103_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-06-16</startDate>
      <endDate>2015-06-16</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160301_0_1334258x1485840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-03-01</startDate>
      <endDate>2016-03-01</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150429_0_1325953x1439200_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-04-29</startDate>
      <endDate>2015-04-29</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20120301_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2012-03-01</startDate>
      <endDate>2012-03-01</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494_1330098x1336058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:PostAcuteMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-05-23</startDate>
      <endDate>2016-05-23</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494_1330098x1328464">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:PostAcuteMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-05-23</startDate>
      <endDate>2016-05-23</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160523_0_1326002x1529494">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:PostAcuteMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-05-23</startDate>
      <endDate>2016-05-23</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-05-02</startDate>
      <endDate>2016-05-02</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160430_0_1326002x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-30</startDate>
      <endDate>2016-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667_1335482x1328677">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixteenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-02-22</startDate>
      <endDate>2016-02-22</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20160222_0_1324497x1326078_1324529x1497667">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixteenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-02-22</startDate>
      <endDate>2016-02-22</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150811_0_1330096x1487397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-08-11</startDate>
      <endDate>2015-08-11</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150805_0_1330098x1336103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-08-05</startDate>
      <endDate>2015-08-05</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150227_0_1325953x1439200_1328644x1425879_1330098x1441752_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:InpatientRehabilitationHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:WeslacoTexasMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-02-27</startDate>
      <endDate>2015-02-27</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_1_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-02-13</startDate>
      <endDate>2015-02-13</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1531683">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:RCCHHealthcarePartnersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1491880">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1331645x1335058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1529444_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherInternationalStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1529443_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherDomesticMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1402629_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:ItalySpainAndUnitedKingdomMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1378289_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1377380_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherUnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1336103_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1336058_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1330786_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1330098x1330589_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026_1330097x1333806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1432756_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">mpw:LtipUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1325790x1331409_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535298">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandFifteenSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandFourteenSeniorUnsecuredNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535296">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandThirteenSeniorUnsecuredNotesDueTwoThousandTwentyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535295">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandTwelveSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1535294">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesDueTwoThousandSixteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1438241">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:SeniorUnsecuredDebtMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1435109">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandElevenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1373899_1330926x1331595">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324529x1373522">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TermLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324497x1326078">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324069x1391302">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:AcquisitionLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0_1324069x1359699">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:WorkingCapitalLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20151231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150114_0_1330096x1487397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-01-14</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20141231_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20141231_0_1325953x1439200_1326002x1455637_1333690x1348598">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:WaterlandPrivateEquityFundMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20141231_0_1325953x1439200_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20161007_0_1326002x1433225_1330097x1333806_1330125x1329075_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:CerberusCapitalManagementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-07</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20161003_0_1325953x1430282_1326002x1534840_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:StewardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-03</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20161001_0_1330098x1330786_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-01</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1487449">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1394035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:NetInvestmentInDirectFinancingLeasesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1325370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1335427x1324247">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1531679">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1529442">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1529441">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1529440">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:AdeptusHealthTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334994x1352243">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncAndOtherAcquisitionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334317x1324867">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1334258x1485840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1534840">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:StewardMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1531683">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:RCCHHealthcarePartnersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1491880">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333817x1327273_1333818x1324536">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1331645x1335058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330328x1447101">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">mpw:MortgageAndOtherLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1529444_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherInternationalStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1529443_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherDomesticMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1402629_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:ItalySpainAndUnitedKingdomMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1378289_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1377380_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OtherUnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1336103_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1336058_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1330786_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1330589_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330098x1325518_1333817x1327273_1333818x1327561">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1330096x1487397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026_1330097x1333806">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1328406x1370426_1331211x1328015_1331645x1335058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="invest:InvestmentAxis">mpw:MortgageLoansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327299x1325719_1331211x1328015_1334317x1324867">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327299x1325719">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1327271x1334937">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseAxis">us-gaap:LoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325953x1388500_1328644x1353251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareFacilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:DevelopmentActivitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325942x1455126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mpw:TwelveOaksFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1432756_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">mpw:LtipUnitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1325790x1331409_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535298">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandFifteenSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535297">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandFourteenSeniorUnsecuredNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535296">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandThirteenSeniorUnsecuredNotesDueTwoThousandTwentyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535295">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandTwelveSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535294">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesDueTwoThousandSixteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535159">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixteenSeniorUnsecuredNotesDueTwoThousandTwentySixMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1535158">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixteenSeniorUnsecuredNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1438241">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:SeniorUnsecuredDebtMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1373899_1330926x1331595">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324529x1373522">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TermLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324199x1385482">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:EquityIncentivePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1531684_1327299x1461762_1331211x1328015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:AcquisitionAndOtherLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mpw:OtherLoansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1391302">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:AcquisitionLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0_1324069x1359699">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:WorkingCapitalLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2016-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160928_0_1330098x1534851">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:WashingtonAndIdahoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-28</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160909_0_1330098x1330786">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-09-09</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1487449">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1394035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:NetInvestmentInDirectFinancingLeasesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1325370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1335427x1324247">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1331645x1335058">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1328480x1476026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1327299x1461762">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mpw:OtherLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1325953x1439200_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1324529x1373522">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TermLoansMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0_1324497x1326078">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150909_0_1325953x1439200_1328480x1409831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:AxaRealEstateMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-09-09</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-08-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1328644x1358103_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-08-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150831_0_1325953x1439200_1326002x1452282_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:JointVenturePartnerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-08-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160722_0_1324529x1531691">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandTwentySixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-07-22</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160720_0_1330098x1330786">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-07-20</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160622_0_1325953x1430282_1330098x1535290_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:OlympiaWashingtonMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-06-22</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160622_0_1325953x1430282_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-06-22</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150727_0_1330063x1330534_1333690x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-07-27</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150616_0_1325953x1439200_1334994x1393133">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-06-16</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160301_0_1334258x1485840_1335482x1328677">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-03-01</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150429_0_1325953x1439200_1326002x1455637">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:MedianMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-04-29</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20120301_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2012-03-01</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20161107_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2016-11-07</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20161031_0_1324529x1373899_1335955x1330134">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160731_0_1324529x1373899_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-07-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160502_0_1325953x1430282_1330098x1325643_1333690x1358103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-05-02</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160430_0_1326002x1439614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mpw:CapellaHealthcareIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-04-30</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20160222_0_1324497x1326078_1324529x1497667">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixteenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-02-22</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150819_0_1324529x1446616">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandFifteenSeniorUnsecuredNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-08-19</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150811_0_1330096x1487397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-08-11</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20150213_0_1325953x1439200_1328644x1358103_1330098x1328460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-02-13</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20111031_0_1324529x1373899_1330926x1409746">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mpw:InterestRateContractTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1610-Q0008_STD_0_20111031_0_1324529x1373899_1330926x1328370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mpw:TwoThousandSixSeniorUnsecuredNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-31</instant>
    </period>
  </context>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_EUR">
    <measure>iso4217:EUR</measure>
  </unit>
  <unit id="Investment">
    <measure>mpw:Investment</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Facility">
    <measure>mpw:Facility</measure>
  </unit>
  <unit id="RenewalOptions">
    <measure>mpw:RenewalOptions</measure>
  </unit>
  <unit id="Property">
    <measure>mpw:Property</measure>
  </unit>
  <unit id="Hospital">
    <measure>mpw:Hospital</measure>
  </unit>
  <unit id="Bed">
    <measure>mpw:Bed</measure>
  </unit>
  <unit id="Leases">
    <measure>mpw:Leases</measure>
  </unit>
  <unit id="Partner">
    <measure>mpw:Partner</measure>
  </unit>
  <unit id="Director">
    <measure>mpw:Director</measure>
  </unit>
  <unit id="Employee">
    <measure>mpw:Employee</measure>
  </unit>

</xbrl>
